CA2487987C - Method and apparatus for photothermal treatment of tissue at depth - Google Patents
Method and apparatus for photothermal treatment of tissue at depth Download PDFInfo
- Publication number
- CA2487987C CA2487987C CA2487987A CA2487987A CA2487987C CA 2487987 C CA2487987 C CA 2487987C CA 2487987 A CA2487987 A CA 2487987A CA 2487987 A CA2487987 A CA 2487987A CA 2487987 C CA2487987 C CA 2487987C
- Authority
- CA
- Canada
- Prior art keywords
- depth
- source
- tissue
- selected region
- optical radiation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
- A61B18/203—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser applying laser energy to the outside of the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00005—Cooling or heating of the probe or tissue immediately surrounding the probe
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00005—Cooling or heating of the probe or tissue immediately surrounding the probe
- A61B2018/00011—Cooling or heating of the probe or tissue immediately surrounding the probe with fluids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00452—Skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00452—Skin
- A61B2018/00458—Deeper parts of the skin, e.g. treatment of vascular disorders or port wine stains
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00452—Skin
- A61B2018/00476—Hair follicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
- A61N2007/0004—Applications of ultrasound therapy
- A61N2007/0008—Destruction of fat cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
Abstract
The present invention provides method and apparatus for treating tissue in a region at depth by applying optical radiation thereto of a wavelength able to reach the depth of the region and of a selected relatively low power for a duration sufficient for the radiation to effect the desired treatment while concurrently cooling tissue above the selected region to protect such tissue.
Treatment may be enhanced by applying mechanical, acoustic or electrical stimulation to the region.
Treatment may be enhanced by applying mechanical, acoustic or electrical stimulation to the region.
Description
METHOD AND APPARATUS FOR PHOTOTHERMAL
TREATMENT OF TISSUE AT DEPTH
BACKGROUND
Field of the Invention This invention relates to methods and apparatus for the photothermal treatment of tissue and, more particularly, to methods and apparatus for photothermal treatment of at least a selected region of tissue located starting at a depth at about the boundary zone of dermal and subdermal tissue and extending therebelow.
Description of the Related Art The benefits of being able to raise and/or lower the temperature in a selected region of tissue for various therapeutic and cosmetic purposes has been known for some time. For instance, heated pads or plates or various forms of electromagnetic radiation, including microwave radiation, electricity,infrared radiation and ultrasound have previously been used for heating subdermal muscles, ligaments, bones and the like to, for example, increase blood flow, to otherwise promote the healing of various injuries and other damage, and for various therapeutic purposes, such as frostbite or hyperthermia treatment, treatment of poor blood circulation, physical therapy, stimulation of collagen, cellulite treatment, adrenergic stimulation, wound healing, psoriasis treatment, body reshaping, non-invasive wrinkle removal, etc. The heating of tissues has also been utilized as a potential treatment for removing cancers or other undesired growths, infections and the like. Heating may be applied over a small localized area, over a larger area, for example to the hands or feet, or over larger regions of tissue, including the entire body.
Since most of the techniques described above involve applying energy to tissue at depth through the patient's skin surface, peak temperature generally occurs at or near the patient's skin surface and decrease, sometimes significantly, with depth. Further, while microwaves or ultrasonic and other acoustic radiation have been used in the past for certain heating treatments at depth, as disclosed in, for example, U.S. Patent No. 5,871,524 to Knowlton, U.S. Patent No.
TREATMENT OF TISSUE AT DEPTH
BACKGROUND
Field of the Invention This invention relates to methods and apparatus for the photothermal treatment of tissue and, more particularly, to methods and apparatus for photothermal treatment of at least a selected region of tissue located starting at a depth at about the boundary zone of dermal and subdermal tissue and extending therebelow.
Description of the Related Art The benefits of being able to raise and/or lower the temperature in a selected region of tissue for various therapeutic and cosmetic purposes has been known for some time. For instance, heated pads or plates or various forms of electromagnetic radiation, including microwave radiation, electricity,infrared radiation and ultrasound have previously been used for heating subdermal muscles, ligaments, bones and the like to, for example, increase blood flow, to otherwise promote the healing of various injuries and other damage, and for various therapeutic purposes, such as frostbite or hyperthermia treatment, treatment of poor blood circulation, physical therapy, stimulation of collagen, cellulite treatment, adrenergic stimulation, wound healing, psoriasis treatment, body reshaping, non-invasive wrinkle removal, etc. The heating of tissues has also been utilized as a potential treatment for removing cancers or other undesired growths, infections and the like. Heating may be applied over a small localized area, over a larger area, for example to the hands or feet, or over larger regions of tissue, including the entire body.
Since most of the techniques described above involve applying energy to tissue at depth through the patient's skin surface, peak temperature generally occurs at or near the patient's skin surface and decrease, sometimes significantly, with depth. Further, while microwaves or ultrasonic and other acoustic radiation have been used in the past for certain heating treatments at depth, as disclosed in, for example, U.S. Patent No. 5,871,524 to Knowlton, U.S. Patent No.
5,769,879 to Richards, et al., U.S. Patent No. 5,507,790 to Weiss, or U.S.
Patent No. 5,143,063 to Feliner, since such radiation, particularly microwaves, are potentially mutagenic and can otherwise result in cell or systemic damage and, particularly for acoustic sources, are relatively expensive, and may not be practical for large-area treatment, these techniques have had limited use for the heating of tissues.
While optical and near infrared (NIR) radiation ( collectively referred to hereinafter as "optical radiation" is generally both less expensive and, being non-mutagenic, safer than microwaves radiation, the use of optical radiation has heretofore not been considered suitable for most applications involving heating of tissue at depth, the term "tissue at depth" as used herein meaning tissue at the border zone of the dermis and hypodermis, some of which tissue may be in the lower dermis, mostly at a depth deeper than 1 mm, and tissue below this border zone to a depth of up to about 50 mm The reason why this radiation has not been considered suitable is because such radiation is both highly scattered and highly absorbed in surface layers of tissue, precluding significant portions of such radiation from reaching the tissue regions at depth to cause heating thereof. In view of the energy losses due to scattering and absorption, substantial optical ( including NIR) energy must be applied in order for enough such energy to reach a region of tissues at depth to have a desired effect. However, such high energy can cause damage to the surface layers of tissue, making it difficult to achieve desired photothermal treatments in tissue regions at depth. For these reasons, optical radiation has heretofore had at most limited value for therapeutic and cosmetic treatments on tissue at depth.
Further, while heating of tissue at depth alone is useful for many treatments, there are treatments, for example to relieve pain and stiffness in muscles or joints, where heating in conjunction with massage or other mechanical stimulation, ultrasound or other acoustic stimulation or electrical stimulation of the tissue may also be useful.
Thus, a need exists for improved method and apparatus for photothermal treatment of tissue regions at depth, and in particular for treatment of subdermal regions of tissue, and for method and apparatus for combining heating with stimulation in such regions for various treatments.
SUMMARY OF THE INVENTION
The present invention generally relates to methods and apparatus for photothermal treatment, both therapeutic and cosmetic, of tissue located at depth in a patient's body, as this term has previously been defined. Optical radiation utilized in practicing the invention is at a wavelength or wavelength band which is neither highly scattered in the patient's skin nor highly absorbed by water in tissue so that the maximum quantity of such radiation can reach the treatment region at depth. The wavelength utilized typically is between about 600 nm and about 1850 nm, more preferably between about 800 nm and about 1350nm, and most preferably between about 1050 nm and about 1250 nm. Other potential ranges for certain depths of tissue are set forth in Table 1. The longer the wavelength, the lower the scattering;
however, outside of the indicated bands, water absorption is so high that little radiation can reach tissue at depth. While the tissue to be treated may be a chromophore at the wavelength(s) utilized within the above bands, this is not a limitation on the invention, and absorption by water, and to a lesser extent fat or lipid, in the region is generally sufficient to achieve the desired heating. In some applications, absorption at certain wavelengths can be increased by delivering a suitable chromophore to the treatment region. The optical radiation source utilized may be a monochromatic source, such as a laser or light emitting diode (LED), or inay be a wide spectrum source such as a halogen lamp or arc lamp. Where a wide spectrum source is used, filtering or shifting of wavelengths outside the above bands may be performed.
The source may also be a pulsed source or a continuous wave (CW) source.
Natural light sources such the sun can also be used to practice this invention. Where the source is a pulsed source, the source typically remains over a treatment region for the duration of each pulse, or a train of pulses may be applied. Where the source is a (CW) source, it is typically moved over the surface of the patients skin at a selected rate, the rate of movement determining the dwell time over a given treatment region.
The invention also requires that cooling be applied to the patient's skin surface concurrently with the application of optical radiation thereto. While the radiation reaches the tissue at depth to be treated quickly to begin the heating thereof, cooling propagates as a cold wave protecting tissue above the treatment region and moving the depth of maximum heating further into the skin. Ideally the cooling wave propagates to a depth just above the treatment region, but does not extend to the treatment region at least until sufficient energy has been delivered to the treatment region to effect the desired treatment Cooling may also be applied to the patient's skin prior to the application of radiation thereto to more effectively protect tissue above the treatment region and to more rapidly result in maximum heat being at or near the desired depth. This may also permit higher energy and shorter duration for the radiation source. The head used to apply the radiation may also be used to apply cooling.
Patent No. 5,143,063 to Feliner, since such radiation, particularly microwaves, are potentially mutagenic and can otherwise result in cell or systemic damage and, particularly for acoustic sources, are relatively expensive, and may not be practical for large-area treatment, these techniques have had limited use for the heating of tissues.
While optical and near infrared (NIR) radiation ( collectively referred to hereinafter as "optical radiation" is generally both less expensive and, being non-mutagenic, safer than microwaves radiation, the use of optical radiation has heretofore not been considered suitable for most applications involving heating of tissue at depth, the term "tissue at depth" as used herein meaning tissue at the border zone of the dermis and hypodermis, some of which tissue may be in the lower dermis, mostly at a depth deeper than 1 mm, and tissue below this border zone to a depth of up to about 50 mm The reason why this radiation has not been considered suitable is because such radiation is both highly scattered and highly absorbed in surface layers of tissue, precluding significant portions of such radiation from reaching the tissue regions at depth to cause heating thereof. In view of the energy losses due to scattering and absorption, substantial optical ( including NIR) energy must be applied in order for enough such energy to reach a region of tissues at depth to have a desired effect. However, such high energy can cause damage to the surface layers of tissue, making it difficult to achieve desired photothermal treatments in tissue regions at depth. For these reasons, optical radiation has heretofore had at most limited value for therapeutic and cosmetic treatments on tissue at depth.
Further, while heating of tissue at depth alone is useful for many treatments, there are treatments, for example to relieve pain and stiffness in muscles or joints, where heating in conjunction with massage or other mechanical stimulation, ultrasound or other acoustic stimulation or electrical stimulation of the tissue may also be useful.
Thus, a need exists for improved method and apparatus for photothermal treatment of tissue regions at depth, and in particular for treatment of subdermal regions of tissue, and for method and apparatus for combining heating with stimulation in such regions for various treatments.
SUMMARY OF THE INVENTION
The present invention generally relates to methods and apparatus for photothermal treatment, both therapeutic and cosmetic, of tissue located at depth in a patient's body, as this term has previously been defined. Optical radiation utilized in practicing the invention is at a wavelength or wavelength band which is neither highly scattered in the patient's skin nor highly absorbed by water in tissue so that the maximum quantity of such radiation can reach the treatment region at depth. The wavelength utilized typically is between about 600 nm and about 1850 nm, more preferably between about 800 nm and about 1350nm, and most preferably between about 1050 nm and about 1250 nm. Other potential ranges for certain depths of tissue are set forth in Table 1. The longer the wavelength, the lower the scattering;
however, outside of the indicated bands, water absorption is so high that little radiation can reach tissue at depth. While the tissue to be treated may be a chromophore at the wavelength(s) utilized within the above bands, this is not a limitation on the invention, and absorption by water, and to a lesser extent fat or lipid, in the region is generally sufficient to achieve the desired heating. In some applications, absorption at certain wavelengths can be increased by delivering a suitable chromophore to the treatment region. The optical radiation source utilized may be a monochromatic source, such as a laser or light emitting diode (LED), or inay be a wide spectrum source such as a halogen lamp or arc lamp. Where a wide spectrum source is used, filtering or shifting of wavelengths outside the above bands may be performed.
The source may also be a pulsed source or a continuous wave (CW) source.
Natural light sources such the sun can also be used to practice this invention. Where the source is a pulsed source, the source typically remains over a treatment region for the duration of each pulse, or a train of pulses may be applied. Where the source is a (CW) source, it is typically moved over the surface of the patients skin at a selected rate, the rate of movement determining the dwell time over a given treatment region.
The invention also requires that cooling be applied to the patient's skin surface concurrently with the application of optical radiation thereto. While the radiation reaches the tissue at depth to be treated quickly to begin the heating thereof, cooling propagates as a cold wave protecting tissue above the treatment region and moving the depth of maximum heating further into the skin. Ideally the cooling wave propagates to a depth just above the treatment region, but does not extend to the treatment region at least until sufficient energy has been delivered to the treatment region to effect the desired treatment Cooling may also be applied to the patient's skin prior to the application of radiation thereto to more effectively protect tissue above the treatment region and to more rapidly result in maximum heat being at or near the desired depth. This may also permit higher energy and shorter duration for the radiation source. The head used to apply the radiation may also be used to apply cooling.
Another feature of the invention is that the radiation is applied at low power for an extended time, the time varying with the depth of treatment and with the treatment being performed. For example, the time may vary from approximately 2 seconds to approximately 2 hours for depths of approximately 1 mm to 50 mm respectively. Depending on depth, the treatment being performed and other factors, the power density may vary from approximately 0.2 to 50 W/Cm2, more preferably from approximately 0.5 to 20 W/Cm2, and most preferably from 0.5 to 10 W/cmZ
or 0.5 to 5 W/emZ.
In another aspect, the present invention provides an apparatus for treating at least a selected region at depth of a patient while protecting tissue above the selected region, comprising: an optical radiation source for delivering optical radiation at a power of between 0.2-50 W/cmZ to the patient's skin, said power varying at least in part as a function of the depth of said selected region, said optical radiation being applied to said selected region for at least approximately 2 seconds; and a cooling mechanism for cooling tissue above said selected region to a temperature below that of said selected region.
In another aspect, the present invention provides an apparatus for treating at least a selected region at depth of a patient while protecting tissue above the selected region, comprising: an optical radiation source for delivering optical radiation to the patient's skin of at least one wavelength between 600 nm and 1850 nm at a power of between 0.2-10 W/emZ, said power varying at least in part as a function of the depth of said selected region, said optical radiation being applied to said selected region for at least approximately 2 seconds; and a cooling mechanism for cooling tissue above said selected region to a temperature below that of said selected region.
In another aspect, the present invention provides use of the apparatus of the present invention for treating at least a selected region at depth of a patient's body while protecting tissue above the selected region.
In another aspect, the present invention provides use of the apparatus of the present invention for hair management.
In another aspect, the present invention provides an apparatus apparatus for treating at least a selected region at depth of a patient while protecting tissue above the selected region, comprising: an optical radiation source for delivering optical radiation at a power of between 0.2 to 50 W/cm2 to the patient's skin, said power varying at least in part as a function of the depth of said selected region, said optical radiation being applied to said selected region for at least approximately 2 seconds, a filter, wherein said filter includes a water filter to at least attenuate wavelengths from said source which are selectively absorbed by water; and a cooling mechanism for cooling tissue above said selected region to a temperature below that of said selected region.
-4a-In another aspect, the present invention provides an apparatus for treating at least a selected region at depth of a patient while protecting tissue above the selected region, comprising: an optical radiation source for delivering optical radiation to the patient's skin of at least one wavelength between 600 nm and 1850 nm at a power of between 0.2 to 10 W/cm2, said power varying at least in part as a function of the depth of said selected region, said optical radiation being applied to said selected region for at least approximately 2 seconds, a filter, wherein said filter includes a water filter to at least attenuate wavelengths from said source which are selectively absorbed by water; and a cooling mechanism for cooling tissue above said selected region to a temperature below that of said selected region.
Other advantages, novel features, and objects of the invention will become apparent from the following detailed description of the invention when considered in conjunction with the accompanying drawings, which are schematic and which are not intended to be drawn to scale. In the figures, each identical, or substantially similar component that is illustrated in various figures is represented by a single numeral or notation. For purposes of clarity, not every component is labeled in every figure, nor is every component of each embodiment of the invention shown where illustration is not necessary to allow those of ordinary skill in the art to understand the invention.
BRIEF DESCRIPTION OF THE DRAWINGS
Non-limiting embodiments of the present invention will be described by way of example with reference to the accompanying drawings in which:
Fig. 1 is a schematic diagram of one embodiment of the invention, as applied to a tissue sample;
Fig. 2 is a schematic diagram of another embodiment of the invention, showing an internal design configuration;
Fig. 3 is a schematic diagram of another embodiment of the invention, showing another internal design configuration;
Fig. 4 is a schematic diagram of another embodiment of the invention, showing another internal design configuration;
Fig. 5 is a schematic diagram of another embodiment of the invention, showing another internal design configuration;
Fig. 6 is a schematic diagram of another embodiment of the invention, showing another internal design configuration;
Fig. 7 is a schematic diagram illustrating a plurality of devices of the invention being used in conjunction with each other;
or 0.5 to 5 W/emZ.
In another aspect, the present invention provides an apparatus for treating at least a selected region at depth of a patient while protecting tissue above the selected region, comprising: an optical radiation source for delivering optical radiation at a power of between 0.2-50 W/cmZ to the patient's skin, said power varying at least in part as a function of the depth of said selected region, said optical radiation being applied to said selected region for at least approximately 2 seconds; and a cooling mechanism for cooling tissue above said selected region to a temperature below that of said selected region.
In another aspect, the present invention provides an apparatus for treating at least a selected region at depth of a patient while protecting tissue above the selected region, comprising: an optical radiation source for delivering optical radiation to the patient's skin of at least one wavelength between 600 nm and 1850 nm at a power of between 0.2-10 W/emZ, said power varying at least in part as a function of the depth of said selected region, said optical radiation being applied to said selected region for at least approximately 2 seconds; and a cooling mechanism for cooling tissue above said selected region to a temperature below that of said selected region.
In another aspect, the present invention provides use of the apparatus of the present invention for treating at least a selected region at depth of a patient's body while protecting tissue above the selected region.
In another aspect, the present invention provides use of the apparatus of the present invention for hair management.
In another aspect, the present invention provides an apparatus apparatus for treating at least a selected region at depth of a patient while protecting tissue above the selected region, comprising: an optical radiation source for delivering optical radiation at a power of between 0.2 to 50 W/cm2 to the patient's skin, said power varying at least in part as a function of the depth of said selected region, said optical radiation being applied to said selected region for at least approximately 2 seconds, a filter, wherein said filter includes a water filter to at least attenuate wavelengths from said source which are selectively absorbed by water; and a cooling mechanism for cooling tissue above said selected region to a temperature below that of said selected region.
-4a-In another aspect, the present invention provides an apparatus for treating at least a selected region at depth of a patient while protecting tissue above the selected region, comprising: an optical radiation source for delivering optical radiation to the patient's skin of at least one wavelength between 600 nm and 1850 nm at a power of between 0.2 to 10 W/cm2, said power varying at least in part as a function of the depth of said selected region, said optical radiation being applied to said selected region for at least approximately 2 seconds, a filter, wherein said filter includes a water filter to at least attenuate wavelengths from said source which are selectively absorbed by water; and a cooling mechanism for cooling tissue above said selected region to a temperature below that of said selected region.
Other advantages, novel features, and objects of the invention will become apparent from the following detailed description of the invention when considered in conjunction with the accompanying drawings, which are schematic and which are not intended to be drawn to scale. In the figures, each identical, or substantially similar component that is illustrated in various figures is represented by a single numeral or notation. For purposes of clarity, not every component is labeled in every figure, nor is every component of each embodiment of the invention shown where illustration is not necessary to allow those of ordinary skill in the art to understand the invention.
BRIEF DESCRIPTION OF THE DRAWINGS
Non-limiting embodiments of the present invention will be described by way of example with reference to the accompanying drawings in which:
Fig. 1 is a schematic diagram of one embodiment of the invention, as applied to a tissue sample;
Fig. 2 is a schematic diagram of another embodiment of the invention, showing an internal design configuration;
Fig. 3 is a schematic diagram of another embodiment of the invention, showing another internal design configuration;
Fig. 4 is a schematic diagram of another embodiment of the invention, showing another internal design configuration;
Fig. 5 is a schematic diagram of another embodiment of the invention, showing another internal design configuration;
Fig. 6 is a schematic diagram of another embodiment of the invention, showing another internal design configuration;
Fig. 7 is a schematic diagram illustrating a plurality of devices of the invention being used in conjunction with each other;
Fig. 8 is a schematic diagram of another embodiment of the invention, showing yet another internal design configuration;
Fig. 9 is a schematic diagram of another embodiment of the invention having a different configuration;
Fig. 10 is a schematic drawing of a model of tissue, used in certain calculations;
Fig. 11 is a plot of the temperature produced by an embodiment of the invention in a tissue sample versus tissue depth;
Fig. 12 is a plot of a temperature relaxation profile produced by an embodiment of the invention in a tissue; and Fig. 13 is a plot of depth of heating vs. treatment time as determined using Equation 12.
DETAILED DESCRIPTION
Applications in which the invention may be useful include the treatment of varios diseases, particularly, cellulite and subcutaneous fat treatment, physical therapy, muscle and skeletal treatments, including relief of pain and stiffness for muscles and joints, and treatment of spinal cord problems, and treatment of cumulative trauma disorders (CTD's) such as carpel tunnel syndrome (CTS), tendonitis and bursitis, fibromyalgia, lymphedema and cancer therapy.
More specifically with respect to cancer therapy, hyperthermia resulting from utilizing the teachings of this invention may be utilized to treat various skin cancers including, but not limited to, basel cell carcinoma, squamous cell carcinoma, lymphoma and possibly treatment (palliative) of melanoma. Hyperthermia may also enhance the efficacy of radiation, for example x-ray, therapy, chemotherapy, therapy with immunmodulators such as ALDARA or PDT therapy. Such combination therapy may for example reduce required treatment time.
The tissue to be treated may be a collagen-rich tissue. Collagen-rich tissues that may be treated include superficial cortical bone, synovium joint capsules, tendon sheaths, menisci, myofascial interfaces, periosteum, fibrotic muscle, or major nerve trunks. The device may also be used for reshaping procedures such as non-invasive wrinkle removal through stimulation of collagen production in a subsurface region of tissue. Heating of the subsurface region of tissue to a temperature of between 37.5 and 45 C may stimulate generation of new collagen and/or elastin. For example, expression of HSP70 ("Heat Shock Protein") may be stimulated when the tissue is heated to between 41 and 42 C for between 20 and 30 minutes.
Other proteins, cytokins and/or growth factors may also be stimulated or released in response to heating.
Significant new collagen deposition, formation or rearrangement may be possible, which may improve skin appearance or texture, allowing wrinkles, fine lines, scars, stretch marks or other indicators to be removed. In general, there exists a relation between the temperature reached and the time of application that is necessary to stimulate new collagen deposition and prevent irreversible damage. Additionally, multiple treatments may be used in some treatment modalities.
Hypothermia resulting from utilizing the teachings of this invention may also be utilized for hair growth management, and for treatment of psoriasis, scars, rosacea and various conditions of toe and finger nails. For hair growth management, which includes temporary and permanent hair removal and control of hair growth, a dermal or subdermal temperature rise of a few degrees, for example to 42-45 C can produce an anagen effluvium. This could be particularly useful for hair grow management on hairs containing little or no melanin, for example gray, white or blond hairs. The efficacy of such treatment may be enhanced by using wavelengths absorbed by melanin or by performing the treatment in conjunction with other hair removal techniques. Hypothermia may also be used to treat psoriasis, including psoriasis plaques and nail psoriasis. The teachings of this invention may thus be used to treat psoriasis, either alone or conjunction drug treatment, light treatment, for example with an excimer laser, flashlamp, uv or pulse dye laser, or other existing treatment. Scars, having different crosslinking and different denaturation thresholds then normal tissue, may be treated by hypothermia to, for example, reduce turnover, turnover being significantly enhanced for scar tissue. A special handpiece with an aperture adjustable to the shape of the scar may be desirable for treating scars. Hypothermia induced in accordance with the teachings of the invention may also be used to kill demodex mites resident in follicles which cause rosacea.
Finally, hypothermia induced by this invention may be used to enhance or control growth rate of toe or finger nails or to otherwise treat conditions of these nails, for example nail fungus and dystrophic nails. The nail (matrix) is relatively accessible to light treatment. The nails can be cooled by emergence in a water bath and exposed to the light. The mechanism for enhanced nail growth may be enhanced metabolism, blood supply (vasodialation by heat and light) or biostimulation.
The application of thermal energy to tissue may also be used, for example, in physical therapy treatments, such as to enhance or accelerate wound healing or relieve pain. Beneficial effects may include a decrease in joint stiffness, an increase in joint extensibility of collagenous structures such as tendons and scar tissue, pain relief, blood-flow changes, or a decrease in muscle spasm and increase in muscle tone. As another example, large protein molecules may have high absorption coefficients, and the heating of protein-rich collagenous tissues may contribute to healing. A wide variety of conditions may be treated using this invention, for example, but not limited to, strained tendons, tenosynovitis, torn ligaments, tendonitis, bursitis, torn joint capsules, or torn muscles. As yet another example, other processes may be activated or deactivated within the tissue during heating.
For example, heating of the tissue may be used to enhance or modify the activity of a pharmaceutical or another bioactive substance or to facilitate the delivery thereof through the skin. Mechanical or electrical stimulation, such as massage, may be used in conjunction with heating to achieve benefits greater then can be achieved by either alone. Pressure may also be applied to the skin surface above the treatment region to facilitate the treatment.
In another example, when tissue is heated to greater then the damage temperature of the tissue, irreversible changes to the tissue may occur, up to and including cell death, apoptosis or the like. The damage temperature is the temperature by which cells, collagen, or other tissue components may be irreversibly damaged. The damage temperature may be useful in certain therapeutic situations, for example, to damage unwanted cells or other structures, such as collagen, malignant or benign tumors, hair bulb, deep pigmented lesions or fat. Further, by heating tissue to a temperature above the body temperature (typically 37 C), but below the damage temperature, it may be possible to change the dynamics of various biological processes, such as metabolism.
Where the tissue is a tumor, it may be desired to use heat in accordance with the teachings of this invention to kill the tumor, or at least a portion thereof, such as a necrotic center. Where the tissue is an artificially created tissue, such as a tissue-engineered scaffold, preferential heating of the center of the artificial tissue may be used, for example, to stimulate cell division within the tissue, to promote cell division or cell growth within the artificial tissue structure.
In certain embodiments, the present invention may be used for non-invasive or non-destructive reduction of localized fat deposits. For example, the invention may be used to heat fat or adipose cells past their damage temperature, causing cell damage and/or necrosis.
Alternatively, the treated cells may undergo apoptosis, resulting in cell death. The dead cells may then be removed or resorbed into the body, for example, by the body's phagocytic or lymphatic systems. Fat reduction may also be achieved by heating fat or adipose cells to an elevated temperature, but below the damage temperature. For example, the fat cells may be heated to a temperature of between about 41 C and about 45 C. Under these conditions, applying heat to subcutaneous fat may activate lipases or metabolize lipids contained within the adipose tissue found within the subcutaneous fat layer, or blood flow may increase to the heated area. Additionally, "lipolysis," or the process of breaking down fat in the body, may be regulated by enzymes sensitive to temperature, such as HSL ("hormone-sensitive lipase").
Thus, elevating the temperature of the adipose cells may increase the lipolysis rate, and thus contribute to a reduction in subdermal fat in the area being treated. This temperature can be below the temperature for vascular/lymph damage so damaged fatty cells and fatty acids can be easily removed from the treatment region. Additionally, application of the present invention may be used in combination with other fat-reduction techniques, such as medication, exercise, or adrenergic stimulation Heating of subcutaneous fat may also result in increased dermal thickness. Thus, fatty tissue may be replaced by fibrous and dermal tissue, this resulting in improved skin appearance.. . Thermal activation of lymph systems in subcutaneous fat can also be used to treat cellulite by removing proteins from extra cell spaces.
Stated another way, fat and/or cellulite reduction may be achieved utilizing the teachings of this invention by providing an elevated (but below damage threshold - 43-48 C) temperature in the targeted region at depth. The mild hyperthermia initiates biological response through one or several of the following pathways:
I. Increase of activity of enzymes regulating the process of lipolysis, in particular, hormone sensitive lipase (HSL). As a result, decrease of fat stores in hypodermis.
2. Stimulation of blood and lymph flow in the targeted area with multiple positive consequences, including (but not limited to) further decrease in the fat stores and accelerated regeneration of connective tissue.
3. Induction of apoptosis in adipocytes, with subsequent removal of residual cell material by the body's scavenging system.
4. Decrease of lipid's viscosity, resulting in increasing mobility of fat globules and permeability of adipocytes' membranes.
5. Stimulation and or reorganization of the connective tissue surrounding subdermal fat depots with or without concurrent changes of the dermal collagen.
The net result is a shift of balance between fat and connective tissue in hypodermis toward the latter and improved appearance of skin.
Fig. 1 shows an apparatus 100 for one embodiment of the invention. For this apparatus, optical energy 30 from a suitable energy source 1 passes through optical (for example, focusing) device 2, filter 3, cooling mechanism 4 and contact plate 8, before reaching tissue 31.
A suitable optical impedance matching lotion or other suitable substance would typically be applied between plate 8 and tissue 31 to provide enhanced optical and thermal contact. Tissue 31, as shown in Fig. 1, is divided into an upper region 5, which, for applications where radiation is applied to the skin surface, would be the epidermis and dermis, and a lower region 6 which would be a subdermal region in the previous example. Energy 30, possibly in conjunction with one or a combination of focusing from optical device 2, and wavelength selection from filter 3, and with cooling from mechanism 4, results in maximum heating occurring at a selected depth in tissue 31, which depth is, as previously indicated, at or near the junction of regions 5 and 6 or in lower region 6 for this invention. In some embodiments of the invention, certain of these components, such as, for example, filter 3 where a monochromatic source is utilized or optics 2, may not necessarily be present.
In some embodiments of the invention, energy source 1, optical device 2 and/or filter 3 may also require a cooling mechanism. This cooling mechanism may or may not be the same as or connected to cooling mechanism 4 that cools tissue 31 through contact plate 8, as indicated by arrows 32 in Fig. 1. For example, in the embodiment shown in Fig.
1, cooling mechanism 7, shown separately from cooling mechanism 4, is used to cool filter 3. Energy source I may be any suitable optical energy source able to produce optical energy 30 at a wavelength that produces heating within tissue 31 at the depth of a desired treatment region.
The exact energy source, and the exact energy chosen, may be a function of the tissue 31 to be heated, the depth within the tissue at which treatment is desired and of the absorption of that energy in the desired area to be treated. For example, energy source I may be a radiant lamp, a halogen lamp, an incandescent lamp, a arc lamp, a fluorescent lamp, a light emitting diode, a laser (including diode and fiber lasers), the sun or other suitable optical energy source.
Energy source 1 may produce electromagnetic radiation, such as near infrared or visible light radiation over a broad spectrum, over a limited spectrum or at a single wavelength, such as would be produced by a light emitting diode or a laser. In certain cases, a narrow spectral source may be preferable, as the wavelength(s) produced by the energy source may be targeted towards a specific tissue type or may be adapted for reaching a selected depth. In other embodiments, a wide spectral source may be preferable, for example, in systems where the wavelength(s) to be applied to the tissue may change, for example, by applying different filters, depending on the application.
Fig. 9 is a schematic diagram of another embodiment of the invention having a different configuration;
Fig. 10 is a schematic drawing of a model of tissue, used in certain calculations;
Fig. 11 is a plot of the temperature produced by an embodiment of the invention in a tissue sample versus tissue depth;
Fig. 12 is a plot of a temperature relaxation profile produced by an embodiment of the invention in a tissue; and Fig. 13 is a plot of depth of heating vs. treatment time as determined using Equation 12.
DETAILED DESCRIPTION
Applications in which the invention may be useful include the treatment of varios diseases, particularly, cellulite and subcutaneous fat treatment, physical therapy, muscle and skeletal treatments, including relief of pain and stiffness for muscles and joints, and treatment of spinal cord problems, and treatment of cumulative trauma disorders (CTD's) such as carpel tunnel syndrome (CTS), tendonitis and bursitis, fibromyalgia, lymphedema and cancer therapy.
More specifically with respect to cancer therapy, hyperthermia resulting from utilizing the teachings of this invention may be utilized to treat various skin cancers including, but not limited to, basel cell carcinoma, squamous cell carcinoma, lymphoma and possibly treatment (palliative) of melanoma. Hyperthermia may also enhance the efficacy of radiation, for example x-ray, therapy, chemotherapy, therapy with immunmodulators such as ALDARA or PDT therapy. Such combination therapy may for example reduce required treatment time.
The tissue to be treated may be a collagen-rich tissue. Collagen-rich tissues that may be treated include superficial cortical bone, synovium joint capsules, tendon sheaths, menisci, myofascial interfaces, periosteum, fibrotic muscle, or major nerve trunks. The device may also be used for reshaping procedures such as non-invasive wrinkle removal through stimulation of collagen production in a subsurface region of tissue. Heating of the subsurface region of tissue to a temperature of between 37.5 and 45 C may stimulate generation of new collagen and/or elastin. For example, expression of HSP70 ("Heat Shock Protein") may be stimulated when the tissue is heated to between 41 and 42 C for between 20 and 30 minutes.
Other proteins, cytokins and/or growth factors may also be stimulated or released in response to heating.
Significant new collagen deposition, formation or rearrangement may be possible, which may improve skin appearance or texture, allowing wrinkles, fine lines, scars, stretch marks or other indicators to be removed. In general, there exists a relation between the temperature reached and the time of application that is necessary to stimulate new collagen deposition and prevent irreversible damage. Additionally, multiple treatments may be used in some treatment modalities.
Hypothermia resulting from utilizing the teachings of this invention may also be utilized for hair growth management, and for treatment of psoriasis, scars, rosacea and various conditions of toe and finger nails. For hair growth management, which includes temporary and permanent hair removal and control of hair growth, a dermal or subdermal temperature rise of a few degrees, for example to 42-45 C can produce an anagen effluvium. This could be particularly useful for hair grow management on hairs containing little or no melanin, for example gray, white or blond hairs. The efficacy of such treatment may be enhanced by using wavelengths absorbed by melanin or by performing the treatment in conjunction with other hair removal techniques. Hypothermia may also be used to treat psoriasis, including psoriasis plaques and nail psoriasis. The teachings of this invention may thus be used to treat psoriasis, either alone or conjunction drug treatment, light treatment, for example with an excimer laser, flashlamp, uv or pulse dye laser, or other existing treatment. Scars, having different crosslinking and different denaturation thresholds then normal tissue, may be treated by hypothermia to, for example, reduce turnover, turnover being significantly enhanced for scar tissue. A special handpiece with an aperture adjustable to the shape of the scar may be desirable for treating scars. Hypothermia induced in accordance with the teachings of the invention may also be used to kill demodex mites resident in follicles which cause rosacea.
Finally, hypothermia induced by this invention may be used to enhance or control growth rate of toe or finger nails or to otherwise treat conditions of these nails, for example nail fungus and dystrophic nails. The nail (matrix) is relatively accessible to light treatment. The nails can be cooled by emergence in a water bath and exposed to the light. The mechanism for enhanced nail growth may be enhanced metabolism, blood supply (vasodialation by heat and light) or biostimulation.
The application of thermal energy to tissue may also be used, for example, in physical therapy treatments, such as to enhance or accelerate wound healing or relieve pain. Beneficial effects may include a decrease in joint stiffness, an increase in joint extensibility of collagenous structures such as tendons and scar tissue, pain relief, blood-flow changes, or a decrease in muscle spasm and increase in muscle tone. As another example, large protein molecules may have high absorption coefficients, and the heating of protein-rich collagenous tissues may contribute to healing. A wide variety of conditions may be treated using this invention, for example, but not limited to, strained tendons, tenosynovitis, torn ligaments, tendonitis, bursitis, torn joint capsules, or torn muscles. As yet another example, other processes may be activated or deactivated within the tissue during heating.
For example, heating of the tissue may be used to enhance or modify the activity of a pharmaceutical or another bioactive substance or to facilitate the delivery thereof through the skin. Mechanical or electrical stimulation, such as massage, may be used in conjunction with heating to achieve benefits greater then can be achieved by either alone. Pressure may also be applied to the skin surface above the treatment region to facilitate the treatment.
In another example, when tissue is heated to greater then the damage temperature of the tissue, irreversible changes to the tissue may occur, up to and including cell death, apoptosis or the like. The damage temperature is the temperature by which cells, collagen, or other tissue components may be irreversibly damaged. The damage temperature may be useful in certain therapeutic situations, for example, to damage unwanted cells or other structures, such as collagen, malignant or benign tumors, hair bulb, deep pigmented lesions or fat. Further, by heating tissue to a temperature above the body temperature (typically 37 C), but below the damage temperature, it may be possible to change the dynamics of various biological processes, such as metabolism.
Where the tissue is a tumor, it may be desired to use heat in accordance with the teachings of this invention to kill the tumor, or at least a portion thereof, such as a necrotic center. Where the tissue is an artificially created tissue, such as a tissue-engineered scaffold, preferential heating of the center of the artificial tissue may be used, for example, to stimulate cell division within the tissue, to promote cell division or cell growth within the artificial tissue structure.
In certain embodiments, the present invention may be used for non-invasive or non-destructive reduction of localized fat deposits. For example, the invention may be used to heat fat or adipose cells past their damage temperature, causing cell damage and/or necrosis.
Alternatively, the treated cells may undergo apoptosis, resulting in cell death. The dead cells may then be removed or resorbed into the body, for example, by the body's phagocytic or lymphatic systems. Fat reduction may also be achieved by heating fat or adipose cells to an elevated temperature, but below the damage temperature. For example, the fat cells may be heated to a temperature of between about 41 C and about 45 C. Under these conditions, applying heat to subcutaneous fat may activate lipases or metabolize lipids contained within the adipose tissue found within the subcutaneous fat layer, or blood flow may increase to the heated area. Additionally, "lipolysis," or the process of breaking down fat in the body, may be regulated by enzymes sensitive to temperature, such as HSL ("hormone-sensitive lipase").
Thus, elevating the temperature of the adipose cells may increase the lipolysis rate, and thus contribute to a reduction in subdermal fat in the area being treated. This temperature can be below the temperature for vascular/lymph damage so damaged fatty cells and fatty acids can be easily removed from the treatment region. Additionally, application of the present invention may be used in combination with other fat-reduction techniques, such as medication, exercise, or adrenergic stimulation Heating of subcutaneous fat may also result in increased dermal thickness. Thus, fatty tissue may be replaced by fibrous and dermal tissue, this resulting in improved skin appearance.. . Thermal activation of lymph systems in subcutaneous fat can also be used to treat cellulite by removing proteins from extra cell spaces.
Stated another way, fat and/or cellulite reduction may be achieved utilizing the teachings of this invention by providing an elevated (but below damage threshold - 43-48 C) temperature in the targeted region at depth. The mild hyperthermia initiates biological response through one or several of the following pathways:
I. Increase of activity of enzymes regulating the process of lipolysis, in particular, hormone sensitive lipase (HSL). As a result, decrease of fat stores in hypodermis.
2. Stimulation of blood and lymph flow in the targeted area with multiple positive consequences, including (but not limited to) further decrease in the fat stores and accelerated regeneration of connective tissue.
3. Induction of apoptosis in adipocytes, with subsequent removal of residual cell material by the body's scavenging system.
4. Decrease of lipid's viscosity, resulting in increasing mobility of fat globules and permeability of adipocytes' membranes.
5. Stimulation and or reorganization of the connective tissue surrounding subdermal fat depots with or without concurrent changes of the dermal collagen.
The net result is a shift of balance between fat and connective tissue in hypodermis toward the latter and improved appearance of skin.
Fig. 1 shows an apparatus 100 for one embodiment of the invention. For this apparatus, optical energy 30 from a suitable energy source 1 passes through optical (for example, focusing) device 2, filter 3, cooling mechanism 4 and contact plate 8, before reaching tissue 31.
A suitable optical impedance matching lotion or other suitable substance would typically be applied between plate 8 and tissue 31 to provide enhanced optical and thermal contact. Tissue 31, as shown in Fig. 1, is divided into an upper region 5, which, for applications where radiation is applied to the skin surface, would be the epidermis and dermis, and a lower region 6 which would be a subdermal region in the previous example. Energy 30, possibly in conjunction with one or a combination of focusing from optical device 2, and wavelength selection from filter 3, and with cooling from mechanism 4, results in maximum heating occurring at a selected depth in tissue 31, which depth is, as previously indicated, at or near the junction of regions 5 and 6 or in lower region 6 for this invention. In some embodiments of the invention, certain of these components, such as, for example, filter 3 where a monochromatic source is utilized or optics 2, may not necessarily be present.
In some embodiments of the invention, energy source 1, optical device 2 and/or filter 3 may also require a cooling mechanism. This cooling mechanism may or may not be the same as or connected to cooling mechanism 4 that cools tissue 31 through contact plate 8, as indicated by arrows 32 in Fig. 1. For example, in the embodiment shown in Fig.
1, cooling mechanism 7, shown separately from cooling mechanism 4, is used to cool filter 3. Energy source I may be any suitable optical energy source able to produce optical energy 30 at a wavelength that produces heating within tissue 31 at the depth of a desired treatment region.
The exact energy source, and the exact energy chosen, may be a function of the tissue 31 to be heated, the depth within the tissue at which treatment is desired and of the absorption of that energy in the desired area to be treated. For example, energy source I may be a radiant lamp, a halogen lamp, an incandescent lamp, a arc lamp, a fluorescent lamp, a light emitting diode, a laser (including diode and fiber lasers), the sun or other suitable optical energy source.
Energy source 1 may produce electromagnetic radiation, such as near infrared or visible light radiation over a broad spectrum, over a limited spectrum or at a single wavelength, such as would be produced by a light emitting diode or a laser. In certain cases, a narrow spectral source may be preferable, as the wavelength(s) produced by the energy source may be targeted towards a specific tissue type or may be adapted for reaching a selected depth. In other embodiments, a wide spectral source may be preferable, for example, in systems where the wavelength(s) to be applied to the tissue may change, for example, by applying different filters, depending on the application.
As previously indicated, in order to minimize both scattering and absorption of the applied optical radiation, the optical radiation produced by energy source 1 should be radiation with a wavelength which is minimally scattered and absorbed, the available wavelengths decreasing with increasing depth as generally indicated in Table I.
Certain wavelengths may be preferentially absorbed by the tissue to be treated. As one example, if the tissue to be treated includes subcutaneous fat, certain wavelengths may be absorbed more effectively by the fat or adipose cells than by the surrounding tissues. For example, optical radiation having wavelengths around 925 nm, 1206 nm, 1730 nm and 2300 nm may be desirable (see for example U.S. Patent No. 6,605,080, issued August 12, 2003 for suitable ranges); however, only the lower three of these ranges would typically provide sufficient penetration for use in practicing this invention.
Using electromagnetic radiation of these wavelengths, the coefficient of absorption by this radiation in the lipids, and in particular the triglycerides located within the adipose tissue may be greater than that of the absorption coefficient of these wavelengths in water. Thus, these wavelengths when applied to a tissue sample, will preferentially be absorbed by the fat tissue, thus resulting in the preferential heating of this tissue. The selective heating of the fatty tissue can be enhanced by the lower heat capacity of fatty tissue vs. aqueous tissue.
Also, the decreased blood perfusion of the subcutaneous fat vs. the dermis can be used to enhance selective heating of the fatty tissue. Compression sufficient to reduce blood flow within the target area can minimize unwanted heat convection, and therefore heat leakage, from the target area. The compression to the subdermal target area can be made selective by forming a skin fold and applying skin pressure sidewise. This results in compression of the subcutaneous fat and of skin outside the field of optical exposure. The skin on top of the skin fold, which skin is exposed to the optical radiation, is not compressed, and therefore the blood flow therein is not appreciably reduced so long as the length of the skin fold does not exceed a critical length.
Blood flow within the part of the dermis exposed to optical radiation can help to remove unwanted excessive heat in this skin component.
Where optical device 2 is a focusing device, it may be any suitable device able to focus at least a portion of energy 30 arriving from energy source I at tissue 31, and in particular at a selected depth in tissue 31. For example, device 2 may include mirrors, prisms, reflectors, lenses such as Fresnel lenses, collimating lenses or focusing lenses, diffraction gratings, or other optical device.
Certain wavelengths may be preferentially absorbed by the tissue to be treated. As one example, if the tissue to be treated includes subcutaneous fat, certain wavelengths may be absorbed more effectively by the fat or adipose cells than by the surrounding tissues. For example, optical radiation having wavelengths around 925 nm, 1206 nm, 1730 nm and 2300 nm may be desirable (see for example U.S. Patent No. 6,605,080, issued August 12, 2003 for suitable ranges); however, only the lower three of these ranges would typically provide sufficient penetration for use in practicing this invention.
Using electromagnetic radiation of these wavelengths, the coefficient of absorption by this radiation in the lipids, and in particular the triglycerides located within the adipose tissue may be greater than that of the absorption coefficient of these wavelengths in water. Thus, these wavelengths when applied to a tissue sample, will preferentially be absorbed by the fat tissue, thus resulting in the preferential heating of this tissue. The selective heating of the fatty tissue can be enhanced by the lower heat capacity of fatty tissue vs. aqueous tissue.
Also, the decreased blood perfusion of the subcutaneous fat vs. the dermis can be used to enhance selective heating of the fatty tissue. Compression sufficient to reduce blood flow within the target area can minimize unwanted heat convection, and therefore heat leakage, from the target area. The compression to the subdermal target area can be made selective by forming a skin fold and applying skin pressure sidewise. This results in compression of the subcutaneous fat and of skin outside the field of optical exposure. The skin on top of the skin fold, which skin is exposed to the optical radiation, is not compressed, and therefore the blood flow therein is not appreciably reduced so long as the length of the skin fold does not exceed a critical length.
Blood flow within the part of the dermis exposed to optical radiation can help to remove unwanted excessive heat in this skin component.
Where optical device 2 is a focusing device, it may be any suitable device able to focus at least a portion of energy 30 arriving from energy source I at tissue 31, and in particular at a selected depth in tissue 31. For example, device 2 may include mirrors, prisms, reflectors, lenses such as Fresnel lenses, collimating lenses or focusing lenses, diffraction gratings, or other optical device.
Filter 3 may be any suitable filter able to select, or at least partially select, certain wavelengths or wavelength bands from energy source 1. In certain types of filters, a specific set of wavelengths may be blocked by the filter. It is also possible that undesired wavelengths in the energy from source I may be wavelength shifted in ways known in the art so as to enhance the energy available in the desired wavelength bands indicated above and in Table 1.
Thus, filter 3 may include elements designed to absorb, reflect or alter certain wavelengths of electroinagnetic radiation. For example, filter 3 may be used to remove certain types of wavelengths that are absorbed by surrounding tissues. For instance, dermis and epidermis tissues are primarily composed of water, as is much of the rest of the human body. By using a filter that selectively removes wavelengths that excite water molecules, the absorption of these wavelengths by the body may be greatly reduced, which may contribute to a reduction in the amount of heat generated by light absorption in these molecules. Thus, by passing radiation through a water-based filter, those frequencies of radiation which may excite water molecules will be absorbed in the water filter, and will not be transmitted into tissue 31. Thus, a water-based filter may be used to decrease the amount of radiation absorbed in tissue above the treatment region and converted into heat.
In other embodiments, filter 3 may be combined with other elements of the device, for example, cooling system 4 or cooling mechanism 7. Thus, water may both attenuate energy 30 arising from energy source 1, as well as cool the contact plate, and tissue in contact with the contact plate, or various other components of the device. More than one filter or filter type may also be present.
Fig. I shows a cooling mechanism 4 adjacent to the surface of tissue 31.
Cooling mechanism 4 may be any suitable cooling mechanism able to reduce the temperature of tissue 31. Heat energy 32 may be drawn from tissue 31 across contact plate 8 into cooling mechanism 4. For example, cooling system 4 may be air or other suitable gas that is blown over contact plate 8, cooling water, or a cooling oil or other fluid. Mixtures of these substances, such as an oil and water mixture, may also be envisioned. Cooling mechanism 4 may have any suitable configuration, for example, a flat plate, a series of conducting pipes, a sheathing blanket, or a series of channels for the passage of air, or other gases, or liquid across plate 8. For example, in one embodiment, cooling system 4 may be a water-cooled contact plate. In another embodiment, cooling mechanism 4 may be a series of channels carrying a coolant fluid or a refrigerant fluid (for example, a cryogen), which channels are in contact with tissue 31 or with plate 8. In yet another embodiment, cooling system 4 may comprise a water or refrigerant fluid (for example R134A) spray, a cool air spray or air flow across the surface of tissue 31. In other embodiments, cooling may be accomplished through chemical reactions (for example, endothermic reactions), or through electronic cooling, such as Peltier cooling. In yet other embodiments, cooling mechanism 4 may have more than one type of coolant, or cooling mechanism 4 and/or contact plate 8 may be absent, for example, in embodiments where the tissue is cooled passively or directly, for example, through a cryogenic or other suitable spray. Sensors or other monitoring devices may also be embedded in cooling mechanism 4, for example, to monitor the temperature, or determine the degree of cooling required by tissue 31, and be manually or electronically controlled.
In certain cases, cooling mechanism 4 may be used to maintain the surface temperature of tissue 31 at its normal temperature, which may be, for example, 37 or 32 C, depending on the type of tissue being heated. In other embodiments, cooling mechanism 4 may be used to decrease the temperature of the surface of tissue 31 to a temperature below the normal temperature of that type of tissue. For example, cooling mechanism 4 may be able to decrease the surface temperature of tissue 31 to, for example, a range between 25 C
and -5 C.
In some embodiments of the invention, such as shown in Fig. 1, energy 30 from energy source I may pass through cooling mechanism 4. In these types of configurations, cooling mechanism 4 may be constructed out of materials able to transmit at least a portion of energy 30, for example, air, water or other gases or fluids, glass, or a clear plastic. In other embodiments, cooling mechanism 4 may be formed out of a series of discrete channels, and energy 30 may pass between these channels. In other embodiments of the invention, energy 30 may not be directed through cooling mechanism 4. For example, in the embodiment shown in Fig. 8, energy source 19 and cooling system 18 may be positioned on opposite sides of chamber 17.
Contact plate 8 may be made out of a suitable heat transfer material, and also, where the plate contacts tissue 31, of a material having a good optical match with the tissue. Sapphire is an example of a suitable material for plate 8. In some embodiments, contact plate 8 may have a high degree of thermal conductivity, for example, to allow cooling of the surface of the tissue by cooling mechanism 4. In other embodiments, contact plate 8 may be an integral part of cooling mechanism 4, or be absent. Contact plate 8 may be made out of a deformable or viscoelastic material in some embodiments of the invention, for example, a gel such as a hydrogel. In other embodiments, contact plate 8 may be made of a solid material, such as a glass, a crystal such as sapphire, or a plastic. In some embodiments of the invention, such as shown in Fig. 1, energy 30 from energy source 1 may pass through contact plate 8. In these configurations, contact plate 8 may be constructed out of materials able to transmit at least a portion of energy 30, for example glass, sapphire, or a clear plastic, or contact plate 8 may be constructed in such a way as to allow at least a portion of energy 30 to pass through contact plate 8, for example, via a series of holes within contact plate 8.
In certain embodiments of the invention, various components of system 100 may require cooling. For example, in the embodiment shown in Fig. 1, optical device 2 and filter 3 may be cooled by cooling mechanism 7. The design of cooling mechanism 7 may be a function of the components used in the construction of the apparatus. Cooling mechanism 7 and cooling mechanism 4, in Fig. 1, are illustrated as separate systems. However, in other embodiments, cooling mechanism 7 and cooling mechanism 4 may be part of the same system, or one or both may be absent. Cooling mechanism 7 may be any suitable cooling mechanism known in the art, such as air, water, or an oil. Mixtures of these substances, such as an oil and water mixture, may also be envisioned. Cooling of the components may be accomplished through convective or conductive cooling.
One or more of energy source 1, optical device 2, filter 3, cooling mechanism 4, or cooling mechanism 7 may be electronically controlled. For example, sensors embedded in cooling mechanism 4 or contact plate 8 may determine the amount of energy reaching tissue 31, and may direct energy source 1 to produce more or less energy or may direct cooling mechanism 4 to increase or decrease cooling, depending on the application.
Other sensors and the like may be embedded in any of the components illustrated herein. The controls may be, for example, electronically preprogrammed, or manually operable.
The present invention is not limited to treating a specific region or area of tissue. For example, as illustrated in Figs. 8 and 9, the invention may be constructed in such a way as to treat an entire person. For example, in Fig. 8, chamber 17 contains cooling mechanism 18 and energy source 19. Cooling mechanism 18 may be cooled in the same ways described above for cooling mechanisms 4 and 7. Energy source 19 may contain, for example, a series of lamps or other energy sources, optionally surrounded by filters 40. In this embodiment, filters 40 are built into the side of chamber 17. Fig. 9 shows another design, where chamber 17 has a cooling mechanism 18, but does not contain an energy source. Instead, energy 42 from the sun 41 or another energy source, such as an external lamp, is directed to chamber 17, for example, directly, by means of reflectors 20, or by means of a lens such as Fresnel lens 19. The patient may be cooled within the chamber by air flow or other suitable cooling mechanism 18.
Thus, filter 3 may include elements designed to absorb, reflect or alter certain wavelengths of electroinagnetic radiation. For example, filter 3 may be used to remove certain types of wavelengths that are absorbed by surrounding tissues. For instance, dermis and epidermis tissues are primarily composed of water, as is much of the rest of the human body. By using a filter that selectively removes wavelengths that excite water molecules, the absorption of these wavelengths by the body may be greatly reduced, which may contribute to a reduction in the amount of heat generated by light absorption in these molecules. Thus, by passing radiation through a water-based filter, those frequencies of radiation which may excite water molecules will be absorbed in the water filter, and will not be transmitted into tissue 31. Thus, a water-based filter may be used to decrease the amount of radiation absorbed in tissue above the treatment region and converted into heat.
In other embodiments, filter 3 may be combined with other elements of the device, for example, cooling system 4 or cooling mechanism 7. Thus, water may both attenuate energy 30 arising from energy source 1, as well as cool the contact plate, and tissue in contact with the contact plate, or various other components of the device. More than one filter or filter type may also be present.
Fig. I shows a cooling mechanism 4 adjacent to the surface of tissue 31.
Cooling mechanism 4 may be any suitable cooling mechanism able to reduce the temperature of tissue 31. Heat energy 32 may be drawn from tissue 31 across contact plate 8 into cooling mechanism 4. For example, cooling system 4 may be air or other suitable gas that is blown over contact plate 8, cooling water, or a cooling oil or other fluid. Mixtures of these substances, such as an oil and water mixture, may also be envisioned. Cooling mechanism 4 may have any suitable configuration, for example, a flat plate, a series of conducting pipes, a sheathing blanket, or a series of channels for the passage of air, or other gases, or liquid across plate 8. For example, in one embodiment, cooling system 4 may be a water-cooled contact plate. In another embodiment, cooling mechanism 4 may be a series of channels carrying a coolant fluid or a refrigerant fluid (for example, a cryogen), which channels are in contact with tissue 31 or with plate 8. In yet another embodiment, cooling system 4 may comprise a water or refrigerant fluid (for example R134A) spray, a cool air spray or air flow across the surface of tissue 31. In other embodiments, cooling may be accomplished through chemical reactions (for example, endothermic reactions), or through electronic cooling, such as Peltier cooling. In yet other embodiments, cooling mechanism 4 may have more than one type of coolant, or cooling mechanism 4 and/or contact plate 8 may be absent, for example, in embodiments where the tissue is cooled passively or directly, for example, through a cryogenic or other suitable spray. Sensors or other monitoring devices may also be embedded in cooling mechanism 4, for example, to monitor the temperature, or determine the degree of cooling required by tissue 31, and be manually or electronically controlled.
In certain cases, cooling mechanism 4 may be used to maintain the surface temperature of tissue 31 at its normal temperature, which may be, for example, 37 or 32 C, depending on the type of tissue being heated. In other embodiments, cooling mechanism 4 may be used to decrease the temperature of the surface of tissue 31 to a temperature below the normal temperature of that type of tissue. For example, cooling mechanism 4 may be able to decrease the surface temperature of tissue 31 to, for example, a range between 25 C
and -5 C.
In some embodiments of the invention, such as shown in Fig. 1, energy 30 from energy source I may pass through cooling mechanism 4. In these types of configurations, cooling mechanism 4 may be constructed out of materials able to transmit at least a portion of energy 30, for example, air, water or other gases or fluids, glass, or a clear plastic. In other embodiments, cooling mechanism 4 may be formed out of a series of discrete channels, and energy 30 may pass between these channels. In other embodiments of the invention, energy 30 may not be directed through cooling mechanism 4. For example, in the embodiment shown in Fig. 8, energy source 19 and cooling system 18 may be positioned on opposite sides of chamber 17.
Contact plate 8 may be made out of a suitable heat transfer material, and also, where the plate contacts tissue 31, of a material having a good optical match with the tissue. Sapphire is an example of a suitable material for plate 8. In some embodiments, contact plate 8 may have a high degree of thermal conductivity, for example, to allow cooling of the surface of the tissue by cooling mechanism 4. In other embodiments, contact plate 8 may be an integral part of cooling mechanism 4, or be absent. Contact plate 8 may be made out of a deformable or viscoelastic material in some embodiments of the invention, for example, a gel such as a hydrogel. In other embodiments, contact plate 8 may be made of a solid material, such as a glass, a crystal such as sapphire, or a plastic. In some embodiments of the invention, such as shown in Fig. 1, energy 30 from energy source 1 may pass through contact plate 8. In these configurations, contact plate 8 may be constructed out of materials able to transmit at least a portion of energy 30, for example glass, sapphire, or a clear plastic, or contact plate 8 may be constructed in such a way as to allow at least a portion of energy 30 to pass through contact plate 8, for example, via a series of holes within contact plate 8.
In certain embodiments of the invention, various components of system 100 may require cooling. For example, in the embodiment shown in Fig. 1, optical device 2 and filter 3 may be cooled by cooling mechanism 7. The design of cooling mechanism 7 may be a function of the components used in the construction of the apparatus. Cooling mechanism 7 and cooling mechanism 4, in Fig. 1, are illustrated as separate systems. However, in other embodiments, cooling mechanism 7 and cooling mechanism 4 may be part of the same system, or one or both may be absent. Cooling mechanism 7 may be any suitable cooling mechanism known in the art, such as air, water, or an oil. Mixtures of these substances, such as an oil and water mixture, may also be envisioned. Cooling of the components may be accomplished through convective or conductive cooling.
One or more of energy source 1, optical device 2, filter 3, cooling mechanism 4, or cooling mechanism 7 may be electronically controlled. For example, sensors embedded in cooling mechanism 4 or contact plate 8 may determine the amount of energy reaching tissue 31, and may direct energy source 1 to produce more or less energy or may direct cooling mechanism 4 to increase or decrease cooling, depending on the application.
Other sensors and the like may be embedded in any of the components illustrated herein. The controls may be, for example, electronically preprogrammed, or manually operable.
The present invention is not limited to treating a specific region or area of tissue. For example, as illustrated in Figs. 8 and 9, the invention may be constructed in such a way as to treat an entire person. For example, in Fig. 8, chamber 17 contains cooling mechanism 18 and energy source 19. Cooling mechanism 18 may be cooled in the same ways described above for cooling mechanisms 4 and 7. Energy source 19 may contain, for example, a series of lamps or other energy sources, optionally surrounded by filters 40. In this embodiment, filters 40 are built into the side of chamber 17. Fig. 9 shows another design, where chamber 17 has a cooling mechanism 18, but does not contain an energy source. Instead, energy 42 from the sun 41 or another energy source, such as an external lamp, is directed to chamber 17, for example, directly, by means of reflectors 20, or by means of a lens such as Fresnel lens 19. The patient may be cooled within the chamber by air flow or other suitable cooling mechanism 18.
In Fig. 2, another embodiment of the invention is shown. In this embodiment, a lamp 9, for example an incandescent lamp, is used as the energy source. Lamp 9 is surrounded by a specially coated reflector 10 to maximize light delivery efficiency to the treatment region of tissue 31. A fluid 13 may pass between contact plate 8 and filter 3. Contact plate 8, cooled by fluid 13, may cool the surface of the tissue to which it is applied. In Fig.
3, lamp 9 has been replaced by a monochromatic light emitting element 11 and lens 12, element 11 being, for example a laser diode, other suitable laser or a light emitting diode. As in the embodiment shown in Fig. 2, contact plate 8 and filter 3 are cooled by fluid 13 flowing therebetween; these two components may also be cooled by flow of cold liquid gas, for example R134A, from a pressurized can. Thus, this embodiment illustrates how a monocromatic element 11 may be used as the energy source.
A different type of cooling mechanism is illustrated in Fig. 4. In Fig. 4, energy arising from energy source 1 is reflected using reflector 10 through filter 3, a transparent isolating material 16, and contact plate 8. Two fluids are used to cool the filter and the contact plate.
Upper fluid 14 flows between filter 3 and isolating material 16, while lower fluid 15 passes between isolating material 16 and contact plate 8. Fluids 14 and 15, in this embodiment, may not be the same fluid; however, in other embodiments, the two fluids may be the same fluid, or have a common reservoir. Contact plate 8, in this embodiment, may be made out of, for exainple, a transparent or a semi-transparent material, such as a glass, plastic or sapphire.
Alternatively, contact plate 8 may be formed out of an opaque material, but have openings to allow energy to pass through contact plate 8. A similar embodiment of the invention is shown in Fig. 5, where the energy source I has been replaced by an element that produces discrete wavelengths, such as a light emitting diode or a laser diode 11. Optional lens 12 has also been added to the system as illustrated in Fig. 5.
In certain embodiments of the invention, contact plate 8 may be absent. For example, in the embodiment shown in Fig. 6, no contact plate is used, and fluid 13 (for example a liquid, gas such as air or a spray) passes or flows directly over the surface of tissue 31. Legs 42 connected to the device may be constructed in such a manner as to correctly position filter 3 over the surface of the tissue. Legs 42 may be any component able to maintain a proper distance between the surface of tissue 31 and device 100. In some embodiments of the invention, legs 42 may be constructed out of a flexible or a semi-solid substance that, for example, may conform to the surface of tissue 31, such as a gel. In other embodiments of the invention, legs 42 may be constructed out of a solid substance, such as rubber or plastic. Legs 42 may have any arrangement underneath the device that allows for the proper positioning of the device relative to the tissue. For example, legs 42 may be arranged in a triangular or a square pattern. ln other embodiments of the invention, legs 42 may be a ring or a series of bars that surrounds the area being treated or legs 42 may be absent.
More than one device 100 of this invention may be used simultaneously. For example, in Fig. 7, a series of devices 100 have been arranged into a semicircular pattern. These devices may be linked together to treat large areas of a subject's body. Additionally, the devices may be interconnected in such a way as to provide flexibility, so that, for example, the apparatus inay conform to the contours of the body. For example, the device may be worn as a belt, a leg wrap, an arm wrap, or wrapped around the torso. Devices 100 may also be mounted to a chair, bed or other suitable surface for the treatment of a patient's back, thighs and/or buttocks.
Alternatively, devices 100 may be used to create an array of small island areas within a larger area (see for example U.S. Patent No. 6,997,923, issued February 14, 2006).
This may, for example, be a safer alternative to large area heating, particularly for extended treatment regimens. By optiinizing the spacing between treated areas, for example, through the addition of "masks" in filter 3 between energy source 1 and tissue 31 that block portions of the energy arising from energy source 1, and/or through the use of multiple separate devices 100 as is shown in Fig. 7, treatment of the subdermal tissue may be maximized, while causing a minimal amount of patient discomfort, and/or allowing faster recovery time.
Where optical source 1 is a continuous wave (CW) or other long duration source, device 100 for various of the embodiments may be slid or scanned over the surface of the patient's skin to overlie successive treatment regions, the dwell time, and thus the treatmentduration, for each such region being a function of the rate at which the device is movedThe device may also include a cooling mechanism ahead of the portion of the device under source 1 to precool skin above the treatment region (see for example issued U.S. Patents Nos. 6,273,884 and 6,511,475).
Any of the embodiments can include a contact sensor to assure good optical and thermal coupling, and systems operating in the sliding mode may also include one or more motion sensors to control radiation delivery, cooling and other functions dependent on scanning speed, to enhance system safety and for other reasons.
In addition to coupling the deep heating treatment of this invention with deep cooling to enhance treatment of fat, bone, muscle, etc., device 100 may also include a massager, vibrator or other mechanical stimulation device or a DC or other suitable electrical stimulation source.
3, lamp 9 has been replaced by a monochromatic light emitting element 11 and lens 12, element 11 being, for example a laser diode, other suitable laser or a light emitting diode. As in the embodiment shown in Fig. 2, contact plate 8 and filter 3 are cooled by fluid 13 flowing therebetween; these two components may also be cooled by flow of cold liquid gas, for example R134A, from a pressurized can. Thus, this embodiment illustrates how a monocromatic element 11 may be used as the energy source.
A different type of cooling mechanism is illustrated in Fig. 4. In Fig. 4, energy arising from energy source 1 is reflected using reflector 10 through filter 3, a transparent isolating material 16, and contact plate 8. Two fluids are used to cool the filter and the contact plate.
Upper fluid 14 flows between filter 3 and isolating material 16, while lower fluid 15 passes between isolating material 16 and contact plate 8. Fluids 14 and 15, in this embodiment, may not be the same fluid; however, in other embodiments, the two fluids may be the same fluid, or have a common reservoir. Contact plate 8, in this embodiment, may be made out of, for exainple, a transparent or a semi-transparent material, such as a glass, plastic or sapphire.
Alternatively, contact plate 8 may be formed out of an opaque material, but have openings to allow energy to pass through contact plate 8. A similar embodiment of the invention is shown in Fig. 5, where the energy source I has been replaced by an element that produces discrete wavelengths, such as a light emitting diode or a laser diode 11. Optional lens 12 has also been added to the system as illustrated in Fig. 5.
In certain embodiments of the invention, contact plate 8 may be absent. For example, in the embodiment shown in Fig. 6, no contact plate is used, and fluid 13 (for example a liquid, gas such as air or a spray) passes or flows directly over the surface of tissue 31. Legs 42 connected to the device may be constructed in such a manner as to correctly position filter 3 over the surface of the tissue. Legs 42 may be any component able to maintain a proper distance between the surface of tissue 31 and device 100. In some embodiments of the invention, legs 42 may be constructed out of a flexible or a semi-solid substance that, for example, may conform to the surface of tissue 31, such as a gel. In other embodiments of the invention, legs 42 may be constructed out of a solid substance, such as rubber or plastic. Legs 42 may have any arrangement underneath the device that allows for the proper positioning of the device relative to the tissue. For example, legs 42 may be arranged in a triangular or a square pattern. ln other embodiments of the invention, legs 42 may be a ring or a series of bars that surrounds the area being treated or legs 42 may be absent.
More than one device 100 of this invention may be used simultaneously. For example, in Fig. 7, a series of devices 100 have been arranged into a semicircular pattern. These devices may be linked together to treat large areas of a subject's body. Additionally, the devices may be interconnected in such a way as to provide flexibility, so that, for example, the apparatus inay conform to the contours of the body. For example, the device may be worn as a belt, a leg wrap, an arm wrap, or wrapped around the torso. Devices 100 may also be mounted to a chair, bed or other suitable surface for the treatment of a patient's back, thighs and/or buttocks.
Alternatively, devices 100 may be used to create an array of small island areas within a larger area (see for example U.S. Patent No. 6,997,923, issued February 14, 2006).
This may, for example, be a safer alternative to large area heating, particularly for extended treatment regimens. By optiinizing the spacing between treated areas, for example, through the addition of "masks" in filter 3 between energy source 1 and tissue 31 that block portions of the energy arising from energy source 1, and/or through the use of multiple separate devices 100 as is shown in Fig. 7, treatment of the subdermal tissue may be maximized, while causing a minimal amount of patient discomfort, and/or allowing faster recovery time.
Where optical source 1 is a continuous wave (CW) or other long duration source, device 100 for various of the embodiments may be slid or scanned over the surface of the patient's skin to overlie successive treatment regions, the dwell time, and thus the treatmentduration, for each such region being a function of the rate at which the device is movedThe device may also include a cooling mechanism ahead of the portion of the device under source 1 to precool skin above the treatment region (see for example issued U.S. Patents Nos. 6,273,884 and 6,511,475).
Any of the embodiments can include a contact sensor to assure good optical and thermal coupling, and systems operating in the sliding mode may also include one or more motion sensors to control radiation delivery, cooling and other functions dependent on scanning speed, to enhance system safety and for other reasons.
In addition to coupling the deep heating treatment of this invention with deep cooling to enhance treatment of fat, bone, muscle, etc., device 100 may also include a massager, vibrator or other mechanical stimulation device or a DC or other suitable electrical stimulation source.
It has been found that such mechanical or electrical stimulation is more effective for hot tissue.
Siinilarly, the effect of deep heating may be enhanced by massage or other stimulation because both heat and cold generally penetrates better in compressed skin and subdermal tissue. Thus, the combination of deep heating and mechanical or electrical stimulation may provide significantly better results then either one alone. Heating may also be enhanced by supplementing the optical heating with, for example electro-stimulation by AC/DC, or additional heating by RF, etc. Tensioning or pressure applied to the skin overlying the treatment region may also enhance treatment effect.
The teachings of this invention may also be utilized for hair removal treatments by targeting the hair bulb, which is generally located in the subcutaneous layer 6. The treatment would be done at low power sufficient to raise the temperature of the fat surrounding the hair bulb, and thus the hair bulb, to roughly 45 C and should be performed for a relatively long time period, for example, 15 minutes. The hair bulb also contains high proliferation water cells which react strongly with the applied radiation to increase bulb temperature, leading to the destruction thereof.
The function and advantages of these and other embodiments of the present invention will be more fully understood from the following examples. These examples are intended to be only illustrative in nature and are not intended to limit the scope of the invention.
Example 1 This example illustrates theoretical calculations corresponding to one embodiment of the invention as applied to human skin.
Initially, a model of the skin was prepared. This model included two layers of tissue possessing distinct optical and thermal properties: dermis and subcutaneous fat (Fig. 10). The presence of fine structures such as the basal layer and the vessel plexus was neglected.
Monochromatic light was assumed to be incident normal to the surface. The input power density was designated as Fo. Both the surface temperature (TS) at depth z=0 and the bottom temperature (Th ) at depth z=h were kept fixed at prescribed levels.
Specifically, Th was set at 37 C due to the temperature stabilization effect of blood and metabolic heat generation on muscle tissue. The objective of this example was to evaluate the steady-state temperature distribution within the skin and to find the characteristic depth zmaX where the steady-state temperature reaches a maximum.
Siinilarly, the effect of deep heating may be enhanced by massage or other stimulation because both heat and cold generally penetrates better in compressed skin and subdermal tissue. Thus, the combination of deep heating and mechanical or electrical stimulation may provide significantly better results then either one alone. Heating may also be enhanced by supplementing the optical heating with, for example electro-stimulation by AC/DC, or additional heating by RF, etc. Tensioning or pressure applied to the skin overlying the treatment region may also enhance treatment effect.
The teachings of this invention may also be utilized for hair removal treatments by targeting the hair bulb, which is generally located in the subcutaneous layer 6. The treatment would be done at low power sufficient to raise the temperature of the fat surrounding the hair bulb, and thus the hair bulb, to roughly 45 C and should be performed for a relatively long time period, for example, 15 minutes. The hair bulb also contains high proliferation water cells which react strongly with the applied radiation to increase bulb temperature, leading to the destruction thereof.
The function and advantages of these and other embodiments of the present invention will be more fully understood from the following examples. These examples are intended to be only illustrative in nature and are not intended to limit the scope of the invention.
Example 1 This example illustrates theoretical calculations corresponding to one embodiment of the invention as applied to human skin.
Initially, a model of the skin was prepared. This model included two layers of tissue possessing distinct optical and thermal properties: dermis and subcutaneous fat (Fig. 10). The presence of fine structures such as the basal layer and the vessel plexus was neglected.
Monochromatic light was assumed to be incident normal to the surface. The input power density was designated as Fo. Both the surface temperature (TS) at depth z=0 and the bottom temperature (Th ) at depth z=h were kept fixed at prescribed levels.
Specifically, Th was set at 37 C due to the temperature stabilization effect of blood and metabolic heat generation on muscle tissue. The objective of this example was to evaluate the steady-state temperature distribution within the skin and to find the characteristic depth zmaX where the steady-state temperature reaches a maximum.
Starting with the problem of light transport within the tissue, scattering in both tissue layers predominated strongly over absorption, allowing the diffuse approximation to be applied. This approach was particularly valid within the wavelength range of 600 nm to 1400 nm, which may also be referred to as the "therapeutic window". The one-dimensional light transport problem in the diffusion approximation for the two-layered tissue model of Fig. 10 can be solved assuming both the tissue irradiance and the light flux to be the continuous functions of coordinate z at the dermis and fat interface. The resulting expression for the tissue irradiance, y, obtained may be written in the following general form:
(1) Vfl(z) = Fo ' z,or LVl - exp(- x, - z) + V2 - exp(xI - z) - V3 - exp(- pt, -z)j z<_ hd, V12(z) = Fo LV4 = exp(- 1C2 ' (z - hd )) - V5 - exp(- Pt2 - (z - hd ))b z > hd where indices I and 2 stand for dermis and subcutaneous fat, respectively. K=
3' uo ' u and Pt -Pu +P, are the diffusion and extinction coefficients for light in the corresponding nZ
4n, zCol = 2 layers, and (n, + n2 ~ is the attenuation coefficient of the collimated light at the surface.
Flux amplitudes V to V5 were determined by the boundary and interface conditioiis. In particular, if the coefficients of refraction of both layers are the same, the interface condition at z = hd is such that both the radiance and the total light flux should be continuous functions of depth.
Turning to the problem of heat conduction within the two-layered tissue model, the time dependent equation of heat conduction in the k-th layer was:
z atTraz't) -ak dz2 Traz't) +Qk(z,t), (2) yielding the following steady-state equation:
ak dzz T (Z) -Qk \Z)1 (3) where ak was the thermal diffusivity of the k-th layer (k = 1,2). The heat source term Qk in these equations describes the generation of heat due to light absorption in the tissue. In the steady-state case, the source term is:
Qk (Z) _ ~ak Ylk (Z), Pk Ck (4) where uak, pk and ck are the coefficient of absorption, density, and specific heat of the k-th layer, respectively.
Boundary conditions were assumed to be T(0) = Ts,T(h) = Th. The solution of Equation (3) was then found to be:
h T:(z)=Th+B=(h-z)- 1 = fdz' Jdz"Q(z"), a2 hd T, (z) = T. + A- z - a=fdz' jdz"Q(z"), i 0 0 (5) where parameters A and B have to be found from the interface conditions. For the case of perfect thermal contact:
T (hd ) = T2 (hd ki dZ Ti (hd ) - k2 dz T2 (hd (6) where and k, and k2 are the thermal conductivities of dermis and fat, respectively.
The analytic expression for the temperature, T(z), was then obtained by substituting Equation (3) into Equations (4) and (5).
A simpler expression for the temperature distribution was obtained for a homogenous medium with no layered structure. In this case, the radiance distribution took the following general form:
V/\z/ = FoZ ,/ LeXP\-,urz/+ ~Od \zJb (7) where the first term was the collimated radiance and the second one was the diffuse radiance given by:
~Od(z) = V2 - exp(- ic = z)- V. = exp(- ,z). (8) The temperature distribution was:
T(z)=T. +(T" -T,.~. h+Fo a {1_V, =r1-e-~''-Z -(1-e-u,=). h1 +K2 Ll -e "-(l -e K")' h t L J
with Vo z.,v /(Pe)= (9) Differentiating Equation (9) with respect to z yields the following implicit expression for the depth zmax, the localized tissue depth at which maximum temperature occurs:
T,,-TS=F V [1_2~ =(1-e-pi -hh'e /``Zma`)+VZ =(1-e-"h-k=h=e-,amax) l5 a f~ K
(10) Tmax =Th - Ts is maximum temperature rise in the tissue at the depth zmax.
Equation (10) was solved numerically. To get an approximate analytic expression, the inequality,ut xwas used, which is typically valid within the therapeutic window. Then, dropping the exponential terms with u,, and solving the simplified equation with respect to zmax yielded the following z -- 1 ln K=(1-V,)+I-exp(-xh) aK (T -T.
K Vz = h = ,u; xh FoVoV2h " ' ) (11) Maximum temperature can be calculated from (9) as Tmax-T(zmax) It can be seen from these results that an increase in F caused the temperature maximum to move upwards, provided the input flux is sufficiently small. At larger value of F , the maximum ceased to move while proceeding to grow in amplitude. The treatment time should be long enough to remove heat from the layer 0 < z <zmax. This time tmiõ was given by the formula:
mnx tmin = 6 = 60) z3 a, = z, +aZ = zz (12) where zi is the depth into dermis and Z2 is depth into subcutaneous fat, and zi + z2 = z is depth of treatment. The numerator constant (6=60) varies within the given range depending on how close the desired temperature is to Tmax, being 6 for Tzmax = 90% Tmax and 60 for Tzmax=99% Tmax. The treatment time must be longer than tmi,,. Fig. 11 shows a typical temperature distribution in the body. Fig. 13 and Table 2 show minimum treatment time as a function of depth of treatment z.
Equations (10), (11), and (12) describe a set of heating and cooling parameters that allow control of both the value and location of the internal temperature maximum. Fig. 11 shows a graph generated using these equations that shows that a broad spectral source, having a proper set of filters, combined with surface cooling, allows the temperature within the adipose layer of tissue to be elevated to a maximum, while maintaining acceptable temperatures surrounding tissue and in particular, in tissue above the treatment region through which the radiation passes.
Thus, this example illustrates theoretical calculations corresponding to one embodiment of the invention.
Example 2 The following prophetic example illustrates treatment parameters for different body layers that may be used in one embodiment of the invention, as applied to human skin.
Based on the calculation illustrated in Example 1, treatment parameters for different layers of the body that may be used in one embodiment of the invention can be determined.
These calculations are summarized in Table 1. The body layers model includes the reticular derinis, dermis subcutaneous fat junction, and subcutaneous fat layer.
Using a broad-spectrum lamp in this embodiment of the invention, the treatment parameters include a surface cooling mechanism able to maintain a surface cooling temperature of between 0 C and 32 C; a broad-spectrum lamp, where the color temperature of the lamp is between 300 K and 3000 K, with filtering of more than 50% of the light having wavelengths of less than 800 nm and greater that 1800 nm, preferably 900 to 1400 nm, and most preferably 1100 to 1250 nm . Depending on depth, the treatment being performed and other factors, the power may vary from approximately 0.2 to 50 W/cm2, and more preferably from approximately 0.5 to 20 W/cm2, with a treatment time of between 2 sec for a 1mm depth and 7300 sec for a 50 mm depth When operating in sliding mode, treatment power and duration increase.
Thus, this prophetic example illustrates exemplary treatment parameters that may be used to heat different layers of the body, in one embodiment of the invention.
(1) Vfl(z) = Fo ' z,or LVl - exp(- x, - z) + V2 - exp(xI - z) - V3 - exp(- pt, -z)j z<_ hd, V12(z) = Fo LV4 = exp(- 1C2 ' (z - hd )) - V5 - exp(- Pt2 - (z - hd ))b z > hd where indices I and 2 stand for dermis and subcutaneous fat, respectively. K=
3' uo ' u and Pt -Pu +P, are the diffusion and extinction coefficients for light in the corresponding nZ
4n, zCol = 2 layers, and (n, + n2 ~ is the attenuation coefficient of the collimated light at the surface.
Flux amplitudes V to V5 were determined by the boundary and interface conditioiis. In particular, if the coefficients of refraction of both layers are the same, the interface condition at z = hd is such that both the radiance and the total light flux should be continuous functions of depth.
Turning to the problem of heat conduction within the two-layered tissue model, the time dependent equation of heat conduction in the k-th layer was:
z atTraz't) -ak dz2 Traz't) +Qk(z,t), (2) yielding the following steady-state equation:
ak dzz T (Z) -Qk \Z)1 (3) where ak was the thermal diffusivity of the k-th layer (k = 1,2). The heat source term Qk in these equations describes the generation of heat due to light absorption in the tissue. In the steady-state case, the source term is:
Qk (Z) _ ~ak Ylk (Z), Pk Ck (4) where uak, pk and ck are the coefficient of absorption, density, and specific heat of the k-th layer, respectively.
Boundary conditions were assumed to be T(0) = Ts,T(h) = Th. The solution of Equation (3) was then found to be:
h T:(z)=Th+B=(h-z)- 1 = fdz' Jdz"Q(z"), a2 hd T, (z) = T. + A- z - a=fdz' jdz"Q(z"), i 0 0 (5) where parameters A and B have to be found from the interface conditions. For the case of perfect thermal contact:
T (hd ) = T2 (hd ki dZ Ti (hd ) - k2 dz T2 (hd (6) where and k, and k2 are the thermal conductivities of dermis and fat, respectively.
The analytic expression for the temperature, T(z), was then obtained by substituting Equation (3) into Equations (4) and (5).
A simpler expression for the temperature distribution was obtained for a homogenous medium with no layered structure. In this case, the radiance distribution took the following general form:
V/\z/ = FoZ ,/ LeXP\-,urz/+ ~Od \zJb (7) where the first term was the collimated radiance and the second one was the diffuse radiance given by:
~Od(z) = V2 - exp(- ic = z)- V. = exp(- ,z). (8) The temperature distribution was:
T(z)=T. +(T" -T,.~. h+Fo a {1_V, =r1-e-~''-Z -(1-e-u,=). h1 +K2 Ll -e "-(l -e K")' h t L J
with Vo z.,v /(Pe)= (9) Differentiating Equation (9) with respect to z yields the following implicit expression for the depth zmax, the localized tissue depth at which maximum temperature occurs:
T,,-TS=F V [1_2~ =(1-e-pi -hh'e /``Zma`)+VZ =(1-e-"h-k=h=e-,amax) l5 a f~ K
(10) Tmax =Th - Ts is maximum temperature rise in the tissue at the depth zmax.
Equation (10) was solved numerically. To get an approximate analytic expression, the inequality,ut xwas used, which is typically valid within the therapeutic window. Then, dropping the exponential terms with u,, and solving the simplified equation with respect to zmax yielded the following z -- 1 ln K=(1-V,)+I-exp(-xh) aK (T -T.
K Vz = h = ,u; xh FoVoV2h " ' ) (11) Maximum temperature can be calculated from (9) as Tmax-T(zmax) It can be seen from these results that an increase in F caused the temperature maximum to move upwards, provided the input flux is sufficiently small. At larger value of F , the maximum ceased to move while proceeding to grow in amplitude. The treatment time should be long enough to remove heat from the layer 0 < z <zmax. This time tmiõ was given by the formula:
mnx tmin = 6 = 60) z3 a, = z, +aZ = zz (12) where zi is the depth into dermis and Z2 is depth into subcutaneous fat, and zi + z2 = z is depth of treatment. The numerator constant (6=60) varies within the given range depending on how close the desired temperature is to Tmax, being 6 for Tzmax = 90% Tmax and 60 for Tzmax=99% Tmax. The treatment time must be longer than tmi,,. Fig. 11 shows a typical temperature distribution in the body. Fig. 13 and Table 2 show minimum treatment time as a function of depth of treatment z.
Equations (10), (11), and (12) describe a set of heating and cooling parameters that allow control of both the value and location of the internal temperature maximum. Fig. 11 shows a graph generated using these equations that shows that a broad spectral source, having a proper set of filters, combined with surface cooling, allows the temperature within the adipose layer of tissue to be elevated to a maximum, while maintaining acceptable temperatures surrounding tissue and in particular, in tissue above the treatment region through which the radiation passes.
Thus, this example illustrates theoretical calculations corresponding to one embodiment of the invention.
Example 2 The following prophetic example illustrates treatment parameters for different body layers that may be used in one embodiment of the invention, as applied to human skin.
Based on the calculation illustrated in Example 1, treatment parameters for different layers of the body that may be used in one embodiment of the invention can be determined.
These calculations are summarized in Table 1. The body layers model includes the reticular derinis, dermis subcutaneous fat junction, and subcutaneous fat layer.
Using a broad-spectrum lamp in this embodiment of the invention, the treatment parameters include a surface cooling mechanism able to maintain a surface cooling temperature of between 0 C and 32 C; a broad-spectrum lamp, where the color temperature of the lamp is between 300 K and 3000 K, with filtering of more than 50% of the light having wavelengths of less than 800 nm and greater that 1800 nm, preferably 900 to 1400 nm, and most preferably 1100 to 1250 nm . Depending on depth, the treatment being performed and other factors, the power may vary from approximately 0.2 to 50 W/cm2, and more preferably from approximately 0.5 to 20 W/cm2, with a treatment time of between 2 sec for a 1mm depth and 7300 sec for a 50 mm depth When operating in sliding mode, treatment power and duration increase.
Thus, this prophetic example illustrates exemplary treatment parameters that may be used to heat different layers of the body, in one embodiment of the invention.
O~ o E Vl Vl N ~ ~n c~ ac ~, J J n ry .+ L do ~i 3 N N O O O
O
L
~~3e ~
G O
E,O 4 17 vi N N ~ N --- n f~C N
n y ti ~ o a F o U U 'n 'n E o n n i ry ~v w ~ E
v ~ o 0o gg o o ooo ~. ? V o O n o O O O N
W n ^-N =--N N V1 ~1 .~ -~
C_ O bOA O
O O o0 0.'TJ" E ta 7 M O O
~ C ~ O O O O
3~ F- N v ri oo ~ cd nn O
cOo O OU C) O O ,__, V N
c a. a M -- v ~
E
A
~ v F C
o E
U : A ~n v~ vi A N N N ~
O N ~ r Vl Vl Vl ~!1 ~!1 N ~O r 1~ O
a ._. ~ v~3 .... ._. -.:
-~. E L doo M~ N ~
.5,.
c~ M ~ oo ~n - N oo .~ A O
Y~.. ~ 0. O .-. -. .~ .... ... .-. ..- ~
(iy O ~ E Ln 00 M V f- M M
},y .--.-. ... ..-. ...
>
cl ~d ~O O ~ 00 ~p 00 OG
o o as o- 0 CC w 7 Q+ O ~
QY a O O O
N ~A N
~
~
O
" N O v _ U _ ct ~ O ~v A v7ic` . v~w Table 2. Minimum treatment time without precooling Depth, mm Treatment time, sec Example 3 5 In this example, a device 100 of this invention substantially as shown in Fig.2 was used to heat subcutaneous fat in the stomach region of a volunteer. Light from a halogen lamp 9 was filtered with a combination of a short cut or high pass filter 8 with an 800 nm cut-off and a 3 mm thick water layer 41. The temperature of water 41 was 12 C, while the temperature of a sapphire plate 8 and of the skin interface was 18 C. Power density was 4W/cm2 and the 10 treatment time was 300 sec. After heating the subcutaneous fat layer for 300 sec., the device was removed, and two thermocouples were immediately implanted 1 mm and 8 mm below the skin surface under the heated region to determine the final, steady-state temperatures and to monitor the temperature relaxation profiles in the dermis and fat layer respectively.
Temperature data recorded by the two thermocouples are shown in Fig. 12. The initial 15 temperature of the subcutaneous fat layer at a depth of 8 mm was found to be approximately 45 C, while the temperature of the dermis, 1 mm below the surface of the skin, was found to be about 40 C and the temperature at the epidermis was 24 C. Over the course of the next several minutes, the temperatures of the dermis and the subcutaneous fat layer decreased towards basal levels of 37 C for the subcutaneous fat layer and approximately 32 C for the dermis.
The same device 100 was used to perform the same test on a 25 mm bulk of pig skin and subcutaneous fat which was placed on a thermally stable plate with a temperature of 37 C.
The power density for this test was 10 W/cm2 and cooling water having a temperature of 4 C
was used. After a treatment time of 300 sec., peak temperature of 53 Cwas found at a depth 14 mm into the fat. The temperature at the epidermis at this time was 38 C. After about 6 weeks, this exposure setting induced reduction of subcutaneous fat without evidence for epidermal damage. A partial replacement of fatty tissue by connective collagen tissue was observed. A
reduction of hair growth was also observed several weeks after this and similar exposure settings, even if a lower temperature rise was obtained and only a single treatment was performed. This clearly emphasized the possibility of using this method to manage unwanted hair growth. Highly proliferating cells like sebocytes within the sebaceous glands or hair matrix cells within the hair follicle are particularly sensitive to heating which can be used to achieve selective effects on these structures even by unselective heating of the depth were these structures are located. Hair matrix cells are also surrounded by fatty cells and the sebaceous glands are generating lipids. The decreased heat capacity for lipids provides additional selective effects. This can also be specifically useful for the treatment of non pigmented hairs that are usually not affected by standard light assisted methods for photoepilation based on selective photothermolysis. Hair growth management may include permanent or temporary hair removal or merely controlling/slowing hair growth rate.
These examples thus illustrates how a device of the invention may be used to heat a subdermal layer of tissue to a temperature significantly higher than normal body temperature and the temperature of surrounding tissue, including tissue between the skin surface and the treatment region..
While several embodiments of the invention have been described and illustrated herein, those of ordinary skill in the art will readily envision a variety of other means and structures for performing the functions and/or obtaining the results and/or advantages described herein, and each of such variations or modifications is deemed to be within the scope of the present invention. More generally, those skilled in the art would readily appreciate that all parameters, dimensions, materials, and configurations described herein are meant to be exemplary and that actual parameters, dimensions, materials, and configurations will depend upon specific applications for which the teachings of the present invention are used. Those skilled in the art will recognize, or be able to ascertain using no more than routine experimentation, many equivalents to the specific embodiments of the invention described herein. It is, therefore, to be understood that the foregoing embodiments are presented by way of example only and that, within the scope of the appended claims and equivalents thereto, the invention may be practiced otherwise than as specifically described. The present invention is directed to each individual feature, system, material and/or method described herein. In addition, any combination of two or more such features, systems, materials and/or methods, if such features, systems, materials and/or methods are not mutually inconsistent, is included within the scope of the present invention. In the claims, all transitional phrases or phrases of inclusion, such as "comprising," "including," "carrying," "having," "containing," and the like are to be understood to be open-ended, i.e. to mean "including but not limited to." Only the transitional phrases or phrases of inclusion "consisting of' and "consisting essentially of' are to be interpreted as closed or semi-closed phrases, respectively.
What is claimed is:
O
L
~~3e ~
G O
E,O 4 17 vi N N ~ N --- n f~C N
n y ti ~ o a F o U U 'n 'n E o n n i ry ~v w ~ E
v ~ o 0o gg o o ooo ~. ? V o O n o O O O N
W n ^-N =--N N V1 ~1 .~ -~
C_ O bOA O
O O o0 0.'TJ" E ta 7 M O O
~ C ~ O O O O
3~ F- N v ri oo ~ cd nn O
cOo O OU C) O O ,__, V N
c a. a M -- v ~
E
A
~ v F C
o E
U : A ~n v~ vi A N N N ~
O N ~ r Vl Vl Vl ~!1 ~!1 N ~O r 1~ O
a ._. ~ v~3 .... ._. -.:
-~. E L doo M~ N ~
.5,.
c~ M ~ oo ~n - N oo .~ A O
Y~.. ~ 0. O .-. -. .~ .... ... .-. ..- ~
(iy O ~ E Ln 00 M V f- M M
},y .--.-. ... ..-. ...
>
cl ~d ~O O ~ 00 ~p 00 OG
o o as o- 0 CC w 7 Q+ O ~
QY a O O O
N ~A N
~
~
O
" N O v _ U _ ct ~ O ~v A v7ic` . v~w Table 2. Minimum treatment time without precooling Depth, mm Treatment time, sec Example 3 5 In this example, a device 100 of this invention substantially as shown in Fig.2 was used to heat subcutaneous fat in the stomach region of a volunteer. Light from a halogen lamp 9 was filtered with a combination of a short cut or high pass filter 8 with an 800 nm cut-off and a 3 mm thick water layer 41. The temperature of water 41 was 12 C, while the temperature of a sapphire plate 8 and of the skin interface was 18 C. Power density was 4W/cm2 and the 10 treatment time was 300 sec. After heating the subcutaneous fat layer for 300 sec., the device was removed, and two thermocouples were immediately implanted 1 mm and 8 mm below the skin surface under the heated region to determine the final, steady-state temperatures and to monitor the temperature relaxation profiles in the dermis and fat layer respectively.
Temperature data recorded by the two thermocouples are shown in Fig. 12. The initial 15 temperature of the subcutaneous fat layer at a depth of 8 mm was found to be approximately 45 C, while the temperature of the dermis, 1 mm below the surface of the skin, was found to be about 40 C and the temperature at the epidermis was 24 C. Over the course of the next several minutes, the temperatures of the dermis and the subcutaneous fat layer decreased towards basal levels of 37 C for the subcutaneous fat layer and approximately 32 C for the dermis.
The same device 100 was used to perform the same test on a 25 mm bulk of pig skin and subcutaneous fat which was placed on a thermally stable plate with a temperature of 37 C.
The power density for this test was 10 W/cm2 and cooling water having a temperature of 4 C
was used. After a treatment time of 300 sec., peak temperature of 53 Cwas found at a depth 14 mm into the fat. The temperature at the epidermis at this time was 38 C. After about 6 weeks, this exposure setting induced reduction of subcutaneous fat without evidence for epidermal damage. A partial replacement of fatty tissue by connective collagen tissue was observed. A
reduction of hair growth was also observed several weeks after this and similar exposure settings, even if a lower temperature rise was obtained and only a single treatment was performed. This clearly emphasized the possibility of using this method to manage unwanted hair growth. Highly proliferating cells like sebocytes within the sebaceous glands or hair matrix cells within the hair follicle are particularly sensitive to heating which can be used to achieve selective effects on these structures even by unselective heating of the depth were these structures are located. Hair matrix cells are also surrounded by fatty cells and the sebaceous glands are generating lipids. The decreased heat capacity for lipids provides additional selective effects. This can also be specifically useful for the treatment of non pigmented hairs that are usually not affected by standard light assisted methods for photoepilation based on selective photothermolysis. Hair growth management may include permanent or temporary hair removal or merely controlling/slowing hair growth rate.
These examples thus illustrates how a device of the invention may be used to heat a subdermal layer of tissue to a temperature significantly higher than normal body temperature and the temperature of surrounding tissue, including tissue between the skin surface and the treatment region..
While several embodiments of the invention have been described and illustrated herein, those of ordinary skill in the art will readily envision a variety of other means and structures for performing the functions and/or obtaining the results and/or advantages described herein, and each of such variations or modifications is deemed to be within the scope of the present invention. More generally, those skilled in the art would readily appreciate that all parameters, dimensions, materials, and configurations described herein are meant to be exemplary and that actual parameters, dimensions, materials, and configurations will depend upon specific applications for which the teachings of the present invention are used. Those skilled in the art will recognize, or be able to ascertain using no more than routine experimentation, many equivalents to the specific embodiments of the invention described herein. It is, therefore, to be understood that the foregoing embodiments are presented by way of example only and that, within the scope of the appended claims and equivalents thereto, the invention may be practiced otherwise than as specifically described. The present invention is directed to each individual feature, system, material and/or method described herein. In addition, any combination of two or more such features, systems, materials and/or methods, if such features, systems, materials and/or methods are not mutually inconsistent, is included within the scope of the present invention. In the claims, all transitional phrases or phrases of inclusion, such as "comprising," "including," "carrying," "having," "containing," and the like are to be understood to be open-ended, i.e. to mean "including but not limited to." Only the transitional phrases or phrases of inclusion "consisting of' and "consisting essentially of' are to be interpreted as closed or semi-closed phrases, respectively.
What is claimed is:
Claims (48)
1. An apparatus for treating at least a selected region at depth of a patient while protecting tissue above the selected region, comprising:
an optical radiation source for delivering optical radiation at a power of between 0.2 to 50 W/cm2 to the patient's skin, said power varying at least in part as a function of the depth of said selected region, said optical radiation being applied to said selected region for at least approximately 2 seconds, a filter, wherein said filter includes a water filter to at least attenuate wavelengths from said source which are selectively absorbed by water;
and a cooling mechanism for cooling tissue above said selected region to a temperature below that of said selected region.
an optical radiation source for delivering optical radiation at a power of between 0.2 to 50 W/cm2 to the patient's skin, said power varying at least in part as a function of the depth of said selected region, said optical radiation being applied to said selected region for at least approximately 2 seconds, a filter, wherein said filter includes a water filter to at least attenuate wavelengths from said source which are selectively absorbed by water;
and a cooling mechanism for cooling tissue above said selected region to a temperature below that of said selected region.
2. The apparatus as claimed in claim 1 wherein said power is 0.5 to 20 W/cm2.
3. The apparatus as claimed in claim 1 wherein said power is 0.5 to 5 W/cm2.
4. The apparatus as claimed in claim 1 wherein said source includes a broadband optical radiation source, and radiation from said broadband source is passed through said filter.
5. The apparatus as claimed in claim 1 wherein said water filter includes chilled water flowing between said broadband source and the patient's body, said flowing chilled water also functioning as part of said mechanism for cooling.
6. The apparatus as claimed in claim 4 wherein said cooling mechanism also cools said filter.
7. The apparatus as claimed in claim 4 including a mechanism for removing heat from said filter.
8. The apparatus as claimed in claim 1 wherein said source includes optics for shaping radiation to be delivered to said selected region.
9. The apparatus as claimed in claim 1 wherein said source is at least primarily at one or more wavelengths between 600 nm and 1850 nm.
10. The apparatus as claimed in claim 9 wherein said source is at least primarily at one or more wavelengths between 800 nm and 1350 nm.
11. The apparatus as claimed in claim 9 wherein said source is at least primarily at one or more wavelengths between 1050 nm and 1250 nm.
12. The apparatus as claimed in claim 1 wherein said optical radiation source and said mechanism are concurrently operated for a period of at least two seconds.
13. The apparatus as claimed in claim 12 wherein said optical radiation source and said mechanism are concurrently operated for a period of at least five seconds.
14. The apparatus as claimed in claim 1 wherein said optical radiation source and said mechanism are concurrently operated for a period of between two seconds and two hours.
15. The apparatus as claimed in claim 12 including a precooling mechanism which cools tissue above said selected region prior to the concurrent operation of said source and said cooling mechanism.
16. The apparatus as claimed in claim 15 wherein said cooling mechanism and said precooling mechanism are the same mechanism.
17. The apparatus as claimed in claim 15 wherein said optical radiation power and said period of concurrent operation vary dependent on whether said precooling mechanism is operated.
18. The apparatus as claimed in claim 1 wherein parameters for said optical radiation source and for said cooling mechanism are selected to achieve a selected temperature as indicated by:
at a selected depth z max determined by:
wherein T s represents surface temperature at depth z=0, T h represents bottom temperature at depth z=h, F0 represents input power density, V0, V1 and V2 represent flux amplitudes , .alpha. represents thermal diffusivity, .kappa. represents diffusion coefficient for light in corresponding layers, µt represents extinction coefficient for light in corresponding layers, k represents thermal conductivity, Z max represents depth where steady-state temperature reaches a maximum, and µt represents the extinction coefficients for light in corresponding layers.
at a selected depth z max determined by:
wherein T s represents surface temperature at depth z=0, T h represents bottom temperature at depth z=h, F0 represents input power density, V0, V1 and V2 represent flux amplitudes , .alpha. represents thermal diffusivity, .kappa. represents diffusion coefficient for light in corresponding layers, µt represents extinction coefficient for light in corresponding layers, k represents thermal conductivity, Z max represents depth where steady-state temperature reaches a maximum, and µt represents the extinction coefficients for light in corresponding layers.
19. The apparatus as claimed in claim 18 wherein the minimum treatment time for the apparatus is determined in accordance with wherein .alpha. k represents thermal diffusivity of k-th layer (k = 1,2), z1 represents depth into dermis, z2 represents depth into subcutaneous fat, and z1 + z2 = z representing depth of treatment.
20. The apparatus as claimed in claim 1 wherein said apparatus is an apparatus for fat reductions, said radiation heating subdermal fat tissue.
21. The apparatus as claimed in claim 1 including a mechanism for stimulating tissue in said selected region.
22. The apparatus as claimed in claim 21 wherein said mechanism for providing stimulation is at least one of a mechanical stimulator, acoustic stimulator and an electrical stimulator.
23. The apparatus as claimed in claim 1 wherein said selected region contains at least one hair bulb, and wherein parameters for said apparatus, including said source, are selected to slowly damage said bulb.
24. An apparatus for treating at least a selected region at depth of a patient while protecting tissue above the selected region, comprising:
an optical radiation source for delivering optical radiation to the patient's skin of at least one wavelength between 600 nm and 1850 nm at a power of between 0.2 to 10 W/cm2, said power varying at least in part as a function of the depth of said selected region, said optical radiation being applied to said selected region for at least approximately 2 seconds, a filter, wherein said filter includes a water filter to at least attenuate wavelengths from said source which are selectively absorbed by water; and a cooling mechanism for cooling tissue above said selected region to a temperature below that of said selected region.
an optical radiation source for delivering optical radiation to the patient's skin of at least one wavelength between 600 nm and 1850 nm at a power of between 0.2 to 10 W/cm2, said power varying at least in part as a function of the depth of said selected region, said optical radiation being applied to said selected region for at least approximately 2 seconds, a filter, wherein said filter includes a water filter to at least attenuate wavelengths from said source which are selectively absorbed by water; and a cooling mechanism for cooling tissue above said selected region to a temperature below that of said selected region.
25. The apparatus as claimed in claim 24 wherein said power is 0.5 to 5 W/cm2.
26. The apparatus as claimed in claim 24 wherein said source includes a broadband optical radiation source, and radiation from said broadband source is passed through said filter.
27. The apparatus as claimed in claim 24 wherein said water filter includes chilled water flowing between said broadband source and the patient's body, said flowing chilled water also functioning as part of said mechanism for cooling.
28. The apparatus as claimed in claim 26 wherein said cooling mechanism also cools said filter.
29. The apparatus as claimed in claim 26 including a mechanism for removing heat from said filter.
30. The apparatus as claimed in claim 24 wherein said source includes optics for shaping radiation to be delivered to said selected region.
31. The apparatus as claimed in claim 24 wherein said source is at least primarily at one or more wavelengths between 800 nm and 1350 nm.
32. The apparatus as claimed in claim 24 wherein said source is at least primarily at one or more wavelengths between 1050 nm and 1250 nm.
33. The apparatus as claimed in claim 24 wherein said optical radiation source and said mechanism are concurrently operated for a period of at least two seconds.
34. The apparatus as claimed in claim 33 wherein said optical radiation source and said mechanism are concurrently operated for a period of at least five seconds.
35. The apparatus as claimed in claim 24 wherein said optical radiation source and said mechanism are concurrently operated for a period of between two seconds and two hours.
36. The apparatus as claimed in claim 33 including a precooling mechanism which cools tissue above said selected region prior to the concurrent operation of said source and said cooling mechanism.
37. The apparatus as claimed in claim 36 wherein said cooling mechanism and said precooling mechanism are the same mechanism.
38. The apparatus as claimed in claim 36 wherein said optical radiation power and said period of concurrent operation vary dependent on whether said precooling mechanism is operated.
39. The apparatus as claimed in claim 24 wherein parameters for said optical radiation source and for said cooling mechanism are selected to achieve a selected temperature as indicated by at a selected depth z max determined by wherein T s represents surface temperature at depth z=0, T h represents bottom temperature at depth z=h, F0 represents input power density, V0, V1 and V2 represent flux amplitudes , .alpha. represents thermal diffusivity, .kappa. represents diffusion coefficient for light in corresponding layers, µt represents extinction coefficient for light in corresponding layers, k represents thermal conductivity, Z max represents depth where steady-state temperature reaches a maximum, and µt represents extinction coefficients for light in corresponding layers.
40. The apparatus as claimed in claim 39 wherein the minimum treatment time for the apparatus is determined in accordance with wherein .alpha. k represents thermal diffusivity of k-th layer (k = 1,2), z1 represents depth into dermis, z2 represents depth into subcutaneous fat, and z1 + z2 = z representing depth of treatment.
41. The apparatus as claimed in claim 24 wherein said apparatus is an apparatus for fat reduction, said radiation heating subdermal fat tissue.
42. The apparatus as claimed in claim 24 including a mechanism for stimulating tissue in said selected region.
43. The apparatus as claimed in claim 42 wherein said mechanism for providing stimulation is at least one of a mechanical stimulator, acoustic stimulator and an electrical stimulator.
44. The apparatus as claimed in claim 24 wherein said selected region contains at least one hair bulb, and wherein parameters for said apparatus, including said source, are selected to slowly damage said bulb.
45. Use of the apparatus as defined in any one of claims 1 to 23 for treating at least a selected region at depth of a patient's body while protecting tissue above the selected region.
46. Use of the apparatus as defined in any one of claims 24 to 44 for treating at least a selected region at depth of a patient's body while protecting tissue above the selected region.
47. Use of the apparatus as defined in any one of claims 1 to 23 for hair management.
48. Use of the apparatus as defined in any one of claims 24 to 44 for hair management.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38987102P | 2002-06-19 | 2002-06-19 | |
US60/389,871 | 2002-06-19 | ||
PCT/US2003/019474 WO2004000150A1 (en) | 2002-06-19 | 2003-06-19 | Method and apparatus for photothermal treatment of tissue at depth |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2487987A1 CA2487987A1 (en) | 2003-12-31 |
CA2487987C true CA2487987C (en) | 2010-04-13 |
Family
ID=36602703
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2487987A Expired - Fee Related CA2487987C (en) | 2002-06-19 | 2003-06-19 | Method and apparatus for photothermal treatment of tissue at depth |
Country Status (10)
Country | Link |
---|---|
US (1) | US7351252B2 (en) |
EP (1) | EP1523283A1 (en) |
JP (1) | JP2006500972A (en) |
CN (1) | CN100482182C (en) |
AU (1) | AU2003238302B2 (en) |
BR (1) | BR0311901A (en) |
CA (1) | CA2487987C (en) |
HK (1) | HK1080341A1 (en) |
IL (2) | IL197542A (en) |
WO (1) | WO2004000150A1 (en) |
Families Citing this family (237)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7452358B2 (en) * | 1996-01-05 | 2008-11-18 | Thermage, Inc. | RF electrode assembly for handpiece |
US7189230B2 (en) * | 1996-01-05 | 2007-03-13 | Thermage, Inc. | Method for treating skin and underlying tissue |
US20030212393A1 (en) * | 1996-01-05 | 2003-11-13 | Knowlton Edward W. | Handpiece with RF electrode and non-volatile memory |
US6517532B1 (en) | 1997-05-15 | 2003-02-11 | Palomar Medical Technologies, Inc. | Light energy delivery head |
US8182473B2 (en) | 1999-01-08 | 2012-05-22 | Palomar Medical Technologies | Cooling system for a photocosmetic device |
US6508813B1 (en) | 1996-12-02 | 2003-01-21 | Palomar Medical Technologies, Inc. | System for electromagnetic radiation dermatology and head for use therewith |
DK0991372T3 (en) | 1997-05-15 | 2004-12-06 | Palomar Medical Tech Inc | Apparatus for dermatological treatment |
US6104959A (en) | 1997-07-31 | 2000-08-15 | Microwave Medical Corp. | Method and apparatus for treating subcutaneous histological features |
AUPP176898A0 (en) * | 1998-02-12 | 1998-03-05 | Moldflow Pty Ltd | Automated machine technology for thermoplastic injection molding |
US20020156471A1 (en) * | 1999-03-09 | 2002-10-24 | Stern Roger A. | Method for treatment of tissue |
US8308784B2 (en) * | 2006-08-24 | 2012-11-13 | Jackson Streeter | Low level light therapy for enhancement of neurologic function of a patient affected by Parkinson's disease |
US7534255B1 (en) | 2003-01-24 | 2009-05-19 | Photothera, Inc | Low level light therapy for enhancement of neurologic function |
US7303578B2 (en) | 2001-11-01 | 2007-12-04 | Photothera, Inc. | Device and method for providing phototherapy to the brain |
US10695577B2 (en) * | 2001-12-21 | 2020-06-30 | Photothera, Inc. | Device and method for providing phototherapy to the heart |
US7316922B2 (en) * | 2002-01-09 | 2008-01-08 | Photothera Inc. | Method for preserving organs for transplant |
CN110522505B (en) | 2002-03-15 | 2023-04-25 | 总医院公司 | System for selective destruction of adipose tissue by controlled cooling |
US8840608B2 (en) | 2002-03-15 | 2014-09-23 | The General Hospital Corporation | Methods and devices for selective disruption of fatty tissue by controlled cooling |
BR0312430A (en) | 2002-06-19 | 2005-04-26 | Palomar Medical Tech Inc | Method and apparatus for treating skin and subcutaneous conditions |
US7713294B2 (en) * | 2002-08-28 | 2010-05-11 | Nomir Medical Technologies, Inc. | Near infrared microbial elimination laser systems (NIMEL) |
US20040126272A1 (en) * | 2002-08-28 | 2004-07-01 | Eric Bornstein | Near infrared microbial elimination laser system |
US20080131968A1 (en) * | 2002-08-28 | 2008-06-05 | Nomir Medical Technologies, Inc. | Near-infrared electromagnetic modification of cellular steady-state membrane potentials |
WO2007014130A2 (en) * | 2005-07-21 | 2007-02-01 | Nomir Medical Technologies, Inc. | Near infrared microbial elimination laser system (nimels) |
US20040156743A1 (en) * | 2002-08-28 | 2004-08-12 | Eric Bornstein | Near infrared microbial elimination laser system |
US8506979B2 (en) | 2002-08-28 | 2013-08-13 | Nomir Medical Technologies, Inc. | Near-infrared electromagnetic modification of cellular steady-state membrane potentials |
US20070213792A1 (en) * | 2002-10-07 | 2007-09-13 | Palomar Medical Technologies, Inc. | Treatment Of Tissue Volume With Radiant Energy |
US20070219604A1 (en) * | 2006-03-20 | 2007-09-20 | Palomar Medical Technologies, Inc. | Treatment of tissue with radiant energy |
EP1555948A2 (en) | 2002-10-23 | 2005-07-27 | Palomar Medical Technologies, Inc. | Phototreatment device for use with coolants and topical substances |
US7255560B2 (en) * | 2002-12-02 | 2007-08-14 | Nomir Medical Technologies, Inc. | Laser augmented periodontal scaling instruments |
EP1596747B1 (en) * | 2003-02-25 | 2016-02-17 | Tria Beauty, Inc. | Eye-safe dermatologic treatment apparatus |
US20040176754A1 (en) * | 2003-03-06 | 2004-09-09 | Island Tobin C. | Method and device for sensing skin contact |
WO2004077020A2 (en) * | 2003-02-25 | 2004-09-10 | Spectragenics, Inc. | Skin sensing method and apparatus |
US7118563B2 (en) * | 2003-02-25 | 2006-10-10 | Spectragenics, Inc. | Self-contained, diode-laser-based dermatologic treatment apparatus |
WO2004075976A2 (en) | 2003-02-25 | 2004-09-10 | Spectragenics, Inc. | Method and apparatus for the treatment of benign pigmented lesions |
WO2004075731A2 (en) * | 2003-02-25 | 2004-09-10 | Spectragenics, Inc. | Acne treatment device and method |
EP1596744B1 (en) * | 2003-02-25 | 2016-02-17 | Tria Beauty, Inc. | Self-contained, eye-safe hair-regrowth-inhibition apparatus and method |
EP2604215B1 (en) * | 2003-02-25 | 2017-10-11 | Tria Beauty, Inc. | Eye-safe dermatologic treatment apparatus and method |
ES2441408T3 (en) * | 2003-03-27 | 2014-02-04 | The General Hospital Corporation | Device for dermatological treatment and fractional skin rejuvenation |
US7470124B2 (en) * | 2003-05-08 | 2008-12-30 | Nomir Medical Technologies, Inc. | Instrument for delivery of optical energy to the dental root canal system for hidden bacterial and live biofilm thermolysis |
US7292893B2 (en) * | 2003-05-16 | 2007-11-06 | Waverx, Inc. | Apparatus and method for the treatment of infectious disease in keratinized tissue |
US7291140B2 (en) * | 2003-07-18 | 2007-11-06 | Cutera, Inc. | System and method for low average power dermatologic light treatment device |
US7722600B2 (en) | 2003-08-25 | 2010-05-25 | Cutera, Inc. | System and method for heating skin using light to provide tissue treatment |
US8915906B2 (en) * | 2003-08-25 | 2014-12-23 | Cutera, Inc. | Method for treatment of post-partum abdominal skin redundancy or laxity |
US8870856B2 (en) | 2003-08-25 | 2014-10-28 | Cutera, Inc. | Method for heating skin using light to provide tissue treatment |
US7326199B2 (en) * | 2003-12-22 | 2008-02-05 | Cutera, Inc. | System and method for flexible architecture for dermatologic treatments utilizing multiple light sources |
US7282060B2 (en) * | 2003-12-23 | 2007-10-16 | Reliant Technologies, Inc. | Method and apparatus for monitoring and controlling laser-induced tissue treatment |
US7184184B2 (en) * | 2003-12-31 | 2007-02-27 | Reliant Technologies, Inc. | High speed, high efficiency optical pattern generator using rotating optical elements |
US7372606B2 (en) * | 2003-12-31 | 2008-05-13 | Reliant Technologies, Inc. | Optical pattern generator using a single rotating component |
US7220254B2 (en) * | 2003-12-31 | 2007-05-22 | Palomar Medical Technologies, Inc. | Dermatological treatment with visualization |
FR2864903B1 (en) * | 2004-01-14 | 2006-09-15 | Optical System Res For Industr | APPARATUS FOR THE TREATMENT, IN PARTICULAR BY LASER, OF A CANCER OR PRECANCEROUS CONDITION |
JP2007520285A (en) | 2004-02-06 | 2007-07-26 | バロレ,ダニエル | Method and apparatus for treating mammalian tissue |
US20050256553A1 (en) * | 2004-02-09 | 2005-11-17 | John Strisower | Method and apparatus for the treatment of respiratory and other infections using ultraviolet germicidal irradiation |
US7052167B2 (en) * | 2004-02-25 | 2006-05-30 | Vanderschuit Carl R | Therapeutic devices and methods for applying therapy |
US8257416B2 (en) * | 2004-02-25 | 2012-09-04 | Vanderschuit Carl R | Therapeutic devices and methods for applying therapy |
US8777935B2 (en) | 2004-02-25 | 2014-07-15 | Tria Beauty, Inc. | Optical sensor and method for identifying the presence of skin |
EP1742588B1 (en) | 2004-04-01 | 2016-10-19 | The General Hospital Corporation | Apparatus for dermatological treatment and tissue reshaping |
WO2005110272A1 (en) * | 2004-05-13 | 2005-11-24 | Waverx, Inc. | Apparatus and method for the treatment of infectious disease in keratinized tissue |
GB0414113D0 (en) | 2004-06-24 | 2004-07-28 | Virulite Distrib Ltd | Cosmetic uses of electromagnetic radiation |
US7837675B2 (en) * | 2004-07-22 | 2010-11-23 | Shaser, Inc. | Method and device for skin treatment with replaceable photosensitive window |
US20060036300A1 (en) * | 2004-08-16 | 2006-02-16 | Syneron Medical Ltd. | Method for lypolisis |
USPP16588P2 (en) * | 2004-11-17 | 2006-05-30 | Koji Goto | Petunia plant named ‘Temari’ |
US7425296B2 (en) | 2004-12-03 | 2008-09-16 | Pressco Technology Inc. | Method and system for wavelength specific thermal irradiation and treatment |
US10857722B2 (en) * | 2004-12-03 | 2020-12-08 | Pressco Ip Llc | Method and system for laser-based, wavelength specific infrared irradiation treatment |
US7780656B2 (en) * | 2004-12-10 | 2010-08-24 | Reliant Technologies, Inc. | Patterned thermal treatment using patterned cryogen spray and irradiation by light |
MX2007007623A (en) * | 2004-12-22 | 2007-08-03 | Gillette Co | Reduction of hair growth. |
US8277495B2 (en) * | 2005-01-13 | 2012-10-02 | Candela Corporation | Method and apparatus for treating a diseased nail |
US20060200212A1 (en) * | 2005-02-17 | 2006-09-07 | Brawn Peter R | Light therapy device for treatment of bone disorders and biostimulation of bone and soft tissue |
US20070248930A1 (en) * | 2005-02-17 | 2007-10-25 | Biolux Research Ltd. | Light therapy apparatus and methods |
EP1858588A2 (en) * | 2005-02-18 | 2007-11-28 | Palomar Medical Technologies, Inc. | Dermatological treatment device |
WO2006093384A1 (en) * | 2005-03-02 | 2006-09-08 | Meridian Co., Ltd. | Adipose resolve apparatus for low-power laser |
US20060265034A1 (en) * | 2005-04-05 | 2006-11-23 | Ams Medical Sa | Microwave devices for treating biological samples and tissue and methods for using same |
US20060229689A1 (en) * | 2005-04-08 | 2006-10-12 | Led Technologies, Llc | LED therapy device |
US7856985B2 (en) | 2005-04-22 | 2010-12-28 | Cynosure, Inc. | Method of treatment body tissue using a non-uniform laser beam |
GB0512038D0 (en) | 2005-06-14 | 2005-07-20 | Dougal Gordon | Therapeutic and cosmetic uses of electromagnetic radiation |
US20070176262A1 (en) * | 2005-08-11 | 2007-08-02 | Ernest Sirkin | Series connection of a diode laser bar |
US20070173799A1 (en) * | 2005-09-01 | 2007-07-26 | Hsia James C | Treatment of fatty tissue adjacent an eye |
AU2006292526A1 (en) | 2005-09-15 | 2007-03-29 | Palomar Medical Technologies, Inc. | Skin optical characterization device |
WO2007038567A1 (en) * | 2005-09-28 | 2007-04-05 | Candela Corporation | Treating cellulite |
US20070078502A1 (en) * | 2005-10-05 | 2007-04-05 | Thermage, Inc. | Method and apparatus for estimating a local impedance factor |
US7957815B2 (en) * | 2005-10-11 | 2011-06-07 | Thermage, Inc. | Electrode assembly and handpiece with adjustable system impedance, and methods of operating an energy-based medical system to treat tissue |
US20070083190A1 (en) * | 2005-10-11 | 2007-04-12 | Yacov Domankevitz | Compression device for a laser handpiece |
US8702691B2 (en) * | 2005-10-19 | 2014-04-22 | Thermage, Inc. | Treatment apparatus and methods for delivering energy at multiple selectable depths in tissue |
US20070106109A1 (en) * | 2005-11-10 | 2007-05-10 | Ly Van B | Device for Stone Therapy and Sexual Stimulation |
US20080102107A1 (en) * | 2005-12-16 | 2008-05-01 | Valex Pharmaceuticals, Llc | Compositions and methods for transdermal joint pain therapy |
WO2007073024A2 (en) | 2005-12-23 | 2007-06-28 | Max Engineering Ltd. | Method of curing inflammatory acne by using carbon lotion and pulsed laser |
US7891362B2 (en) * | 2005-12-23 | 2011-02-22 | Candela Corporation | Methods for treating pigmentary and vascular abnormalities in a dermal region |
US8540703B2 (en) | 2005-12-23 | 2013-09-24 | Lutronic Corporation | Methods for treating skin conditions using laser |
US8033284B2 (en) * | 2006-01-11 | 2011-10-11 | Curaelase, Inc. | Therapeutic laser treatment |
US20070197884A1 (en) * | 2006-01-24 | 2007-08-23 | Nomir Medical Technologies, Inc. | Optical method and device for modulation of biochemical processes in adipose tissue |
US7575589B2 (en) * | 2006-01-30 | 2009-08-18 | Photothera, Inc. | Light-emitting device and method for providing phototherapy to the brain |
US20090254154A1 (en) | 2008-03-18 | 2009-10-08 | Luis De Taboada | Method and apparatus for irradiating a surface with pulsed light |
US10357662B2 (en) * | 2009-02-19 | 2019-07-23 | Pthera LLC | Apparatus and method for irradiating a surface with light |
CN101400299B (en) * | 2006-02-01 | 2013-06-12 | 通用医疗公司 | Apparatus for applying a plurality of electro-magnetic radiations to a sample |
US7854754B2 (en) * | 2006-02-22 | 2010-12-21 | Zeltiq Aesthetics, Inc. | Cooling device for removing heat from subcutaneous lipid-rich cells |
KR100742973B1 (en) * | 2006-02-22 | 2007-07-27 | 주식회사 루트로닉 | Fatty tissue removing using 1444nm beam oscillating nd:yag laser |
KR100649890B1 (en) * | 2006-03-27 | 2006-11-28 | 주식회사 루트로닉 | Control method and control structure of laser beam irradiation by using a contact sensor |
US7662177B2 (en) | 2006-04-12 | 2010-02-16 | Bacoustics, Llc | Apparatus and methods for pain relief using ultrasound waves in combination with cryogenic energy |
BRPI0706055B8 (en) * | 2006-04-28 | 2021-06-22 | Zeltiq Aesthetics Inc | system and set of components to remove heat from lipid-rich subcutaneous cells |
US20070282318A1 (en) * | 2006-05-16 | 2007-12-06 | Spooner Gregory J | Subcutaneous thermolipolysis using radiofrequency energy |
US20080009844A1 (en) * | 2006-06-26 | 2008-01-10 | Ingeborg Rolle | Device for Laser Surgery |
EP2092957B2 (en) * | 2006-06-28 | 2019-11-20 | Medtronic Ardian Luxembourg S.à.r.l. | Systems for thermally-induced renal neuromodulation |
US7586957B2 (en) | 2006-08-02 | 2009-09-08 | Cynosure, Inc | Picosecond laser apparatus and methods for its operation and use |
US20080045933A1 (en) * | 2006-08-15 | 2008-02-21 | Paul Perl | Multi-broadband pulse emitter and a method for applying an effective dermal treatment |
US20080161745A1 (en) * | 2006-09-08 | 2008-07-03 | Oliver Stumpp | Bleaching of contrast enhancing agent applied to skin for use with a dermatological treatment system |
US8192474B2 (en) * | 2006-09-26 | 2012-06-05 | Zeltiq Aesthetics, Inc. | Tissue treatment methods |
US9132031B2 (en) | 2006-09-26 | 2015-09-15 | Zeltiq Aesthetics, Inc. | Cooling device having a plurality of controllable cooling elements to provide a predetermined cooling profile |
US20100049180A1 (en) * | 2007-10-19 | 2010-02-25 | Lockheed Martin Corporation | System and method for conditioning animal tissue using laser light |
WO2008091983A2 (en) * | 2007-01-25 | 2008-07-31 | Thermage, Inc. | Treatment apparatus and methods for inducing microburn patterns in tissue |
US20080221649A1 (en) * | 2007-03-09 | 2008-09-11 | Agustina Echague | Method of sequentially treating tissue |
US8202268B1 (en) | 2007-03-18 | 2012-06-19 | Lockheed Martin Corporation | Method and multiple-mode device for high-power short-pulse laser ablation and CW cauterization of bodily tissues |
US20090024003A1 (en) * | 2007-03-28 | 2009-01-22 | N.V. Organon | Accurate method to assess disease severity in clinical trials concerning psychopathology |
US20080262574A1 (en) * | 2007-04-11 | 2008-10-23 | Eleme Medical Inc. | Use of low intensity light therapy for the treatment of various medical conditions |
WO2009075904A1 (en) | 2007-04-19 | 2009-06-18 | The Foundry, Inc. | Methods, devices, and systems for non-invasive delivery of microwave therapy |
US9149331B2 (en) | 2007-04-19 | 2015-10-06 | Miramar Labs, Inc. | Methods and apparatus for reducing sweat production |
US20100211059A1 (en) | 2007-04-19 | 2010-08-19 | Deem Mark E | Systems and methods for creating an effect using microwave energy to specified tissue |
CN101711134B (en) * | 2007-04-19 | 2016-08-17 | 米勒玛尔实验室公司 | Tissue is applied the system of microwave energy and in organized layer, produces the system of tissue effect |
US9241763B2 (en) | 2007-04-19 | 2016-01-26 | Miramar Labs, Inc. | Systems, apparatus, methods and procedures for the noninvasive treatment of tissue using microwave energy |
US20090036956A1 (en) * | 2007-04-30 | 2009-02-05 | Victor Alexeevich Mikhalylov | Laser treatment system and related methods |
US20080287839A1 (en) | 2007-05-18 | 2008-11-20 | Juniper Medical, Inc. | Method of enhanced removal of heat from subcutaneous lipid-rich cells and treatment apparatus having an actuator |
US20090012515A1 (en) * | 2007-07-06 | 2009-01-08 | Hoenig Peter A | Devices, systems and methods for treating tissues |
US8216218B2 (en) * | 2007-07-10 | 2012-07-10 | Thermage, Inc. | Treatment apparatus and methods for delivering high frequency energy across large tissue areas |
US8523927B2 (en) | 2007-07-13 | 2013-09-03 | Zeltiq Aesthetics, Inc. | System for treating lipid-rich regions |
US20090018625A1 (en) * | 2007-07-13 | 2009-01-15 | Juniper Medical, Inc. | Managing system temperature to remove heat from lipid-rich regions |
US20090018626A1 (en) * | 2007-07-13 | 2009-01-15 | Juniper Medical, Inc. | User interfaces for a system that removes heat from lipid-rich regions |
US20090018624A1 (en) * | 2007-07-13 | 2009-01-15 | Juniper Medical, Inc. | Limiting use of disposable system patient protection devices |
JP2009034235A (en) * | 2007-07-31 | 2009-02-19 | Panasonic Electric Works Co Ltd | Light emitter for controlling hair growth |
JP5179110B2 (en) * | 2007-07-31 | 2013-04-10 | パナソニック株式会社 | Hair growth control light irradiation device |
JP2009034234A (en) * | 2007-07-31 | 2009-02-19 | Panasonic Electric Works Co Ltd | Light emitter for controlling hair growth |
WO2009021225A1 (en) * | 2007-08-08 | 2009-02-12 | Spectragenics, Inc. | Capacitive sensing method and device for detecting skin |
EP3488833A1 (en) | 2007-08-21 | 2019-05-29 | Zeltiq Aesthetics, Inc. | Monitoring the cooling of subcutaneous lipid-rich cells, such as the cooling of adipose tissue |
JP2010075639A (en) * | 2007-10-19 | 2010-04-08 | Shiseido Co Ltd | Method and apparatus for improving skin condition of face and neck |
JP6008463B2 (en) * | 2007-12-07 | 2016-10-19 | ザ ジェネラル ホスピタル コーポレイション | System and apparatus for dermatological treatment |
KR101654863B1 (en) | 2007-12-12 | 2016-09-22 | 미라마 랩스 인코포레이티드 | Systems, apparatus, methods and procedures for the noninvasive treatment of tissue using microwave energy |
ES2471971T3 (en) | 2007-12-12 | 2014-06-27 | Miramar Labs, Inc. | System and apparatus for non-invasive treatment of tissue using microwave energy |
US20090177253A1 (en) * | 2008-01-08 | 2009-07-09 | Oregon Aesthetic Technologies | Skin therapy system |
US20090234338A1 (en) * | 2008-03-11 | 2009-09-17 | Shaser, Inc. | Reducing sensations experienced during light-based dermatologic treatment procedures |
WO2009132355A1 (en) | 2008-04-25 | 2009-10-29 | Tria Beauty, Inc. | Optical sensor and method for identifying the presence of skin and the pigmentation of skin |
GB0812753D0 (en) * | 2008-07-14 | 2008-08-20 | Dougal Gordon R P | Electromagnetic radiation and its therapeutic effect |
US7848035B2 (en) * | 2008-09-18 | 2010-12-07 | Photothera, Inc. | Single-use lens assembly |
US8275442B2 (en) * | 2008-09-25 | 2012-09-25 | Zeltiq Aesthetics, Inc. | Treatment planning systems and methods for body contouring applications |
US9532717B2 (en) * | 2008-10-28 | 2017-01-03 | The Procter & Gamble Company | Method for diagnosing vulvovaginal disorders |
EP2361117A4 (en) * | 2008-11-24 | 2012-05-09 | Gradiant Res Llc | Photothermal treatment of soft tissues |
US20110190749A1 (en) * | 2008-11-24 | 2011-08-04 | Mcmillan Kathleen | Low Profile Apparatus and Method for Phototherapy |
US8603073B2 (en) | 2008-12-17 | 2013-12-10 | Zeltiq Aesthetics, Inc. | Systems and methods with interrupt/resume capabilities for treating subcutaneous lipid-rich cells |
US20100234737A1 (en) * | 2009-03-12 | 2010-09-16 | Miranda Aref Farage | Method for assessing skin irritation using infrared light |
EP2229980B1 (en) * | 2009-03-16 | 2015-08-12 | Nuvolase, Inc. | Treatment of microbiological pathogens in a toe nail with antimicrobial light |
US8399731B2 (en) * | 2009-03-19 | 2013-03-19 | Covidien Lp | Phototherapy wound treatment |
DK2421609T3 (en) * | 2009-04-22 | 2013-04-15 | Radiancy Inc | Device for skin treatment using light and temperature |
WO2010127315A2 (en) | 2009-04-30 | 2010-11-04 | Zeltiq Aesthetics, Inc. | Device, system and method of removing heat from subcutaneous lipid-rich cells |
GB2470927A (en) * | 2009-06-10 | 2010-12-15 | Dezac Group Ltd | Phototherapy apparatus with skin temperature control |
US8814922B2 (en) | 2009-07-22 | 2014-08-26 | New Star Lasers, Inc. | Method for treatment of fingernail and toenail microbial infections using infrared laser heating and low pressure |
US9919168B2 (en) | 2009-07-23 | 2018-03-20 | Palomar Medical Technologies, Inc. | Method for improvement of cellulite appearance |
EP2477586B1 (en) | 2009-09-16 | 2019-07-10 | Board of Regents, The University of Texas System | Altering temperature in a mammalian body |
JP2011110134A (en) * | 2009-11-25 | 2011-06-09 | Panasonic Electric Works Co Ltd | Light irradiation device |
US20110190745A1 (en) * | 2009-12-04 | 2011-08-04 | Uebelhoer Nathan S | Treatment of sweat glands |
US20110172746A1 (en) * | 2010-01-12 | 2011-07-14 | Roger Porter | High Level Laser Therapy Apparatus and Methods |
CN102791227A (en) | 2010-01-25 | 2012-11-21 | 斯尔替克美学股份有限公司 | Home-use applicators for non-invasively removing heat from subcutaneous lipid-rich cells via phase change coolants, and associated devices, systems and methods |
US9308046B2 (en) * | 2010-05-18 | 2016-04-12 | Candela Corporation | Reduction of pain through lower fluence rates and longer treatment times |
US8676338B2 (en) * | 2010-07-20 | 2014-03-18 | Zeltiq Aesthetics, Inc. | Combined modality treatment systems, methods and apparatus for body contouring applications |
WO2012023086A1 (en) | 2010-08-17 | 2012-02-23 | Koninklijke Philips Electronics N.V. | Flexible light therapy device, a plaster and a bandage |
CN101912669B (en) * | 2010-08-31 | 2013-05-22 | 清华大学 | Surface-cooling non-invasive radiation whole-body thermocuring method |
EP2624777B1 (en) | 2010-10-07 | 2019-03-20 | Gradiant Research, Llc | Apparatus for skin cancer thermal therapy |
JP2014503255A (en) * | 2010-12-03 | 2014-02-13 | サイノシュア・インコーポレーテッド | Non-invasive fat reduction with thermal treatment |
US9242118B2 (en) | 2010-12-08 | 2016-01-26 | Biolux Research Ltd. | Methods useful for remodeling maxillofacial bone using light therapy and a functional appliance |
WO2012103242A1 (en) | 2011-01-25 | 2012-08-02 | Zeltiq Aesthetics, Inc. | Devices, application systems and methods with localized heat flux zones for removing heat from subcutaneous lipid-rich cells |
US9314301B2 (en) | 2011-08-01 | 2016-04-19 | Miramar Labs, Inc. | Applicator and tissue interface module for dermatological device |
US9078587B2 (en) * | 2011-10-21 | 2015-07-14 | The Regents Of The University Of California | Method and apparatus for photomagnetic imaging |
US20160220834A1 (en) * | 2011-11-16 | 2016-08-04 | Btl Holdings Limited | Method and system for skin treatment |
US8728064B2 (en) | 2011-12-12 | 2014-05-20 | Candela Corporation | Devices for the treatment of biological tissue |
US9498641B2 (en) | 2012-03-05 | 2016-11-22 | Blue Water Innovations, Llc | Fat reducing device and method utilizing optical emitters |
EP2839552A4 (en) | 2012-04-18 | 2015-12-30 | Cynosure Inc | Picosecond laser apparatus and methods for treating target tissues with same |
DE102012013534B3 (en) | 2012-07-05 | 2013-09-19 | Tobias Sokolowski | Apparatus for repetitive nerve stimulation for the degradation of adipose tissue by means of inductive magnetic fields |
US9993658B2 (en) | 2012-08-16 | 2018-06-12 | Yolo Medical Inc. | Light applicators, systems and methods |
WO2014040014A1 (en) | 2012-09-10 | 2014-03-13 | Dermal Photonics Corporation | Systems and methods for usage replenishment |
US9844460B2 (en) | 2013-03-14 | 2017-12-19 | Zeltiq Aesthetics, Inc. | Treatment systems with fluid mixing systems and fluid-cooled applicators and methods of using the same |
EP2968925B1 (en) | 2013-03-14 | 2020-02-19 | Cynosure, LLC | Electrosurgical systems |
US9545523B2 (en) | 2013-03-14 | 2017-01-17 | Zeltiq Aesthetics, Inc. | Multi-modality treatment systems, methods and apparatus for altering subcutaneous lipid-rich tissue |
WO2014145148A2 (en) | 2013-03-15 | 2014-09-18 | Ellman International, Inc. | Surgical instruments and systems with multimodes of treatments and electrosurgical operation |
US10285757B2 (en) | 2013-03-15 | 2019-05-14 | Cynosure, Llc | Picosecond optical radiation systems and methods of use |
WO2015013502A2 (en) | 2013-07-24 | 2015-01-29 | Miramar Labs, Inc. | Apparatus and methods for the treatment of tissue using microwave energy |
JP6112416B2 (en) * | 2013-09-06 | 2017-04-12 | パナソニックIpマネジメント株式会社 | Light irradiation device for body hair |
USD747800S1 (en) | 2013-09-10 | 2016-01-19 | Dermal Photonics Corporation | Dermatological medical device |
CN105682603A (en) | 2013-10-22 | 2016-06-15 | 碧奥鲁克斯研究有限公司 | Intra-oral light-therapy apparatuses and methods for their use |
US10946210B2 (en) | 2013-11-06 | 2021-03-16 | Blue Water Innovations, Llc | Cellulite and fat reducing device and method utilizing optical emitters |
US9949889B2 (en) | 2013-11-11 | 2018-04-24 | Joylux, Inc. | At-home light-emitting diode and massage device for vaginal rejuvenation |
US9861421B2 (en) | 2014-01-31 | 2018-01-09 | Zeltiq Aesthetics, Inc. | Compositions, treatment systems and methods for improved cooling of lipid-rich tissue |
US10675176B1 (en) | 2014-03-19 | 2020-06-09 | Zeltiq Aesthetics, Inc. | Treatment systems, devices, and methods for cooling targeted tissue |
USD777338S1 (en) | 2014-03-20 | 2017-01-24 | Zeltiq Aesthetics, Inc. | Cryotherapy applicator for cooling tissue |
US10952891B1 (en) | 2014-05-13 | 2021-03-23 | Zeltiq Aesthetics, Inc. | Treatment systems with adjustable gap applicators and methods for cooling tissue |
US10935174B2 (en) | 2014-08-19 | 2021-03-02 | Zeltiq Aesthetics, Inc. | Stress relief couplings for cryotherapy apparatuses |
US10568759B2 (en) | 2014-08-19 | 2020-02-25 | Zeltiq Aesthetics, Inc. | Treatment systems, small volume applicators, and methods for treating submental tissue |
US9907975B1 (en) | 2014-11-19 | 2018-03-06 | Roger D. Porter | Therapeutic laser treatment and transdermal stimulation of stem cell differentiation |
US10518104B2 (en) | 2015-04-23 | 2019-12-31 | Cynosure, Llc | Systems and methods of unattended treatment |
US10737109B2 (en) | 2015-04-23 | 2020-08-11 | Cynosure, Llc | Systems and methods of unattended treatment of a subject's head or neck |
US11491342B2 (en) | 2015-07-01 | 2022-11-08 | Btl Medical Solutions A.S. | Magnetic stimulation methods and devices for therapeutic treatments |
US10569094B2 (en) | 2015-07-01 | 2020-02-25 | Btl Medical Technologies S.R.O. | Aesthetic method of biological structure treatment by magnetic field |
US10478634B2 (en) | 2015-07-01 | 2019-11-19 | Btl Medical Technologies S.R.O. | Aesthetic method of biological structure treatment by magnetic field |
US10821295B1 (en) | 2015-07-01 | 2020-11-03 | Btl Medical Technologies S.R.O. | Aesthetic method of biological structure treatment by magnetic field |
US20180001107A1 (en) | 2016-07-01 | 2018-01-04 | Btl Holdings Limited | Aesthetic method of biological structure treatment by magnetic field |
US10569095B1 (en) | 2015-07-01 | 2020-02-25 | Btl Medical Technologies S.R.O. | Aesthetic method of biological structure treatment by magnetic field |
US10695575B1 (en) | 2016-05-10 | 2020-06-30 | Btl Medical Technologies S.R.O. | Aesthetic method of biological structure treatment by magnetic field |
US11266850B2 (en) | 2015-07-01 | 2022-03-08 | Btl Healthcare Technologies A.S. | High power time varying magnetic field therapy |
US10695576B2 (en) | 2015-07-01 | 2020-06-30 | Btl Medical Technologies S.R.O. | Aesthetic method of biological structure treatment by magnetic field |
US10709894B2 (en) | 2015-07-01 | 2020-07-14 | Btl Medical Technologies S.R.O. | Aesthetic method of biological structure treatment by magnetic field |
US10179085B2 (en) * | 2015-10-02 | 2019-01-15 | Joylux, Inc. | Light-emitting diode and massage device for delivering focused light for vaginal rejuvenation |
ES2892598T3 (en) | 2015-10-19 | 2022-02-04 | Zeltiq Aesthetics Inc | Vascular treatment methods to cool vascular structures |
BR112018008359B1 (en) * | 2015-10-26 | 2022-10-18 | Ojai Retinal Technology, Llc | ADAPTED SYSTEM FOR HEAT TREATMENT OF BIOLOGICAL TISSUES |
US11253717B2 (en) | 2015-10-29 | 2022-02-22 | Btl Healthcare Technologies A.S. | Aesthetic method of biological structure treatment by magnetic field |
JP6833869B2 (en) | 2016-01-07 | 2021-02-24 | ゼルティック エステティックス インコーポレイテッド | Temperature-dependent adhesion between applicator and skin during tissue cooling |
US10765552B2 (en) | 2016-02-18 | 2020-09-08 | Zeltiq Aesthetics, Inc. | Cooling cup applicators with contoured heads and liner assemblies |
SG11201804408XA (en) * | 2016-03-29 | 2018-06-28 | Double H Ltd | Wearable device for reducing body fat using leds and method for operating same |
CN109152606B (en) | 2016-04-11 | 2021-06-22 | 赛诺秀有限责任公司 | System and method for unattended treatment of a subject's head or neck |
US11464993B2 (en) | 2016-05-03 | 2022-10-11 | Btl Healthcare Technologies A.S. | Device including RF source of energy and vacuum system |
US11247039B2 (en) | 2016-05-03 | 2022-02-15 | Btl Healthcare Technologies A.S. | Device including RF source of energy and vacuum system |
US11382790B2 (en) | 2016-05-10 | 2022-07-12 | Zeltiq Aesthetics, Inc. | Skin freezing systems for treating acne and skin conditions |
US11534619B2 (en) | 2016-05-10 | 2022-12-27 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
US10682297B2 (en) | 2016-05-10 | 2020-06-16 | Zeltiq Aesthetics, Inc. | Liposomes, emulsions, and methods for cryotherapy |
US10555831B2 (en) | 2016-05-10 | 2020-02-11 | Zeltiq Aesthetics, Inc. | Hydrogel substances and methods of cryotherapy |
US10583287B2 (en) | 2016-05-23 | 2020-03-10 | Btl Medical Technologies S.R.O. | Systems and methods for tissue treatment |
US10556122B1 (en) | 2016-07-01 | 2020-02-11 | Btl Medical Technologies S.R.O. | Aesthetic method of biological structure treatment by magnetic field |
US11141219B1 (en) | 2016-08-16 | 2021-10-12 | BTL Healthcare Technologies, a.s. | Self-operating belt |
KR102597022B1 (en) | 2016-11-22 | 2023-11-01 | 도미니언 에스테틱 테크놀로지스, 인크. | Systems and methods for cosmetic treatments |
CN106730402A (en) * | 2017-01-05 | 2017-05-31 | 海南瑞韩医学美容医院管理有限公司海口龙华京华城红妆医学美容门诊部 | A kind of hand for treating chloasma has |
US11076879B2 (en) | 2017-04-26 | 2021-08-03 | Zeltiq Aesthetics, Inc. | Shallow surface cryotherapy applicators and related technology |
WO2018211492A1 (en) | 2017-05-18 | 2018-11-22 | Lightfective Ltd. | Methods and devices for treatment of subcutaneous fat |
SG11202000094YA (en) | 2017-06-07 | 2020-02-27 | Cynosure Llc | Fat reduction and improving skin laxity |
US11400308B2 (en) | 2017-11-21 | 2022-08-02 | Cutera, Inc. | Dermatological picosecond laser treatment systems and methods using optical parametric oscillator |
KR102505869B1 (en) | 2018-02-07 | 2023-03-07 | 싸이노슈어, 엘엘씨 | Method and Apparatus for Controlled RF Processing and RF Generator System |
WO2019165426A1 (en) | 2018-02-26 | 2019-08-29 | Cynosure, Inc. | Q-switched cavity dumped sub-nanosecond laser |
KR20210038661A (en) | 2018-07-31 | 2021-04-07 | 젤티크 애스세틱스, 인코포레이티드. | Methods, devices, and systems for improving skin properties |
SI3721939T1 (en) | 2019-04-11 | 2022-10-28 | Btl Healthcare Technologies A.S. | Device for aesthetic treatment of biological structures by radiofrequency and magnetic energy |
USD1005484S1 (en) | 2019-07-19 | 2023-11-21 | Cynosure, Llc | Handheld medical instrument and docking base |
CN111150939A (en) * | 2019-11-18 | 2020-05-15 | 西安交通大学 | Treatment device based on 940nm wavelength laser |
US10864380B1 (en) | 2020-02-29 | 2020-12-15 | Cutera, Inc. | Systems and methods for controlling therapeutic laser pulse duration |
US11253720B2 (en) | 2020-02-29 | 2022-02-22 | Cutera, Inc. | Dermatological systems and methods with handpiece for coaxial pulse delivery and temperature sensing |
US11878167B2 (en) | 2020-05-04 | 2024-01-23 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
BR112022022112A2 (en) | 2020-05-04 | 2022-12-13 | Btl Healthcare Tech A S | DEVICE FOR UNASSISTED PATIENT TREATMENT |
US11896816B2 (en) | 2021-11-03 | 2024-02-13 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
Family Cites Families (175)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE346723A (en) | 1926-11-13 | |||
US2472385A (en) | 1946-07-18 | 1949-06-07 | Michael A Rollman | Massage device |
US3327712A (en) | 1961-09-15 | 1967-06-27 | Ira H Kaufman | Photocoagulation type fiber optical surgical device |
US3538919A (en) | 1967-04-07 | 1970-11-10 | Gregory System Inc | Depilation by means of laser energy |
US3527932A (en) | 1967-11-16 | 1970-09-08 | James J Thomas | Transilluminating flashlight |
US3486070A (en) | 1968-04-29 | 1969-12-23 | Westinghouse Electric Corp | Solid-state constant power ballast for electric discharge device |
US3622743A (en) | 1969-04-28 | 1971-11-23 | Hrand M Muncheryan | Laser eraser and microwelder |
US4456872A (en) | 1969-10-27 | 1984-06-26 | Bose Corporation | Current controlled two-state modulation |
US3693623A (en) | 1970-12-25 | 1972-09-26 | Gregory System Inc | Photocoagulation means and method for depilation |
US3846811A (en) | 1972-03-29 | 1974-11-05 | Canon Kk | Flash unit for use with camera |
US3818914A (en) | 1972-04-17 | 1974-06-25 | Spectroderm Inc | Apparatus and method for treatment of skin disorders |
FR2199453B1 (en) * | 1972-05-12 | 1974-10-25 | Busser Francis | |
US3857015A (en) | 1972-11-08 | 1974-12-24 | O Richardson | Electrically heated heat sealing implement |
US3834391A (en) | 1973-01-19 | 1974-09-10 | Block Carol Ltd | Method and apparatus for photoepilation |
US3900034A (en) | 1974-04-10 | 1975-08-19 | Us Energy | Photochemical stimulation of nerves |
GB1485908A (en) | 1974-05-21 | 1977-09-14 | Nath G | Apparatus for applying light radiation |
US4273109A (en) | 1976-07-06 | 1981-06-16 | Cavitron Corporation | Fiber optic light delivery apparatus and medical instrument utilizing same |
JPS55129327A (en) | 1979-03-28 | 1980-10-07 | Minolta Camera Co Ltd | Constant intensity light emitting strobe device |
JPS56156150A (en) * | 1980-02-27 | 1981-12-02 | Nato Giyuntaa | Photocoagulator |
US4316467A (en) | 1980-06-23 | 1982-02-23 | Lorenzo P. Maun | Control for laser hemangioma treatment system |
US4388924A (en) | 1981-05-21 | 1983-06-21 | Weissman Howard R | Method for laser depilation |
JPS5886178A (en) | 1981-11-18 | 1983-05-23 | 松下電器産業株式会社 | Laser medical apparatus |
US4461294A (en) | 1982-01-20 | 1984-07-24 | Baron Neville A | Apparatus and process for recurving the cornea of an eye |
GB2123287B (en) | 1982-07-09 | 1986-03-05 | Anna Gunilla Sutton | Depilaton device |
AU553836B2 (en) * | 1982-08-27 | 1986-07-31 | Alistair Joseph Blake | Lamp for irradiating tumours |
US4524289A (en) | 1983-04-11 | 1985-06-18 | Xerox Corporation | Flash lamp power supply with reduced capacitance requirements |
US4591762A (en) | 1983-05-31 | 1986-05-27 | Olympus Optical, Co. | Electronic flash |
JPS60123818A (en) | 1983-12-08 | 1985-07-02 | Olympus Optical Co Ltd | Optical transmitter |
US4608978A (en) | 1983-09-26 | 1986-09-02 | Carol Block Limited | Method and apparatus for photoepiltion |
US5140984A (en) | 1983-10-06 | 1992-08-25 | Proclosure, Inc. | Laser healing method and apparatus |
US5108388B1 (en) | 1983-12-15 | 2000-09-19 | Visx Inc | Laser surgery method |
JPS60148567A (en) | 1984-01-13 | 1985-08-05 | 株式会社東芝 | Laser treatment apparatus |
IL75998A0 (en) | 1984-08-07 | 1985-12-31 | Medical Laser Research & Dev C | Laser system for providing target tissue specific energy deposition |
WO1986005676A1 (en) | 1985-03-29 | 1986-10-09 | Politzer Eugene Jim | Method and apparatus for shaving the beard |
US4917084A (en) | 1985-07-31 | 1990-04-17 | C. R. Bard, Inc. | Infrared laser catheter system |
US5196004A (en) | 1985-07-31 | 1993-03-23 | C. R. Bard, Inc. | Infrared laser catheter system |
US5137530A (en) | 1985-09-27 | 1992-08-11 | Sand Bruce J | Collagen treatment apparatus |
GB2184021A (en) | 1985-12-13 | 1987-06-17 | Micra Ltd | Laser treatment apparatus for port wine stains |
US4695697A (en) | 1985-12-13 | 1987-09-22 | Gv Medical, Inc. | Fiber tip monitoring and protection assembly |
FR2597744A1 (en) | 1986-04-29 | 1987-10-30 | Boussignac Georges | CARDIO-VASCULAR CATHETER FOR LASER SHOOTING |
AU595580B2 (en) | 1986-06-30 | 1990-04-05 | Medical Laser Research Co., Ltd. | Semiconductor laser therapeutic apparatus |
US4926227A (en) | 1986-08-01 | 1990-05-15 | Nanometrics Inc. | Sensor devices with internal packaged coolers |
US4749913A (en) | 1987-04-17 | 1988-06-07 | General Electric Company | Operating circuit for a direct current discharge lamp |
US4745909A (en) | 1987-05-15 | 1988-05-24 | Pelton Robert J | Cold massage tool and method of use thereof |
US4860744A (en) | 1987-11-02 | 1989-08-29 | Raj K. Anand | Thermoelectrically controlled heat medical catheter |
US4930504A (en) | 1987-11-13 | 1990-06-05 | Diamantopoulos Costas A | Device for biostimulation of tissue and method for treatment of tissue |
US4860172A (en) | 1988-01-19 | 1989-08-22 | Biotronics Associates, Inc. | Lamp-based laser simulator |
US5242437A (en) | 1988-06-10 | 1993-09-07 | Trimedyne Laser Systems, Inc. | Medical device applying localized high intensity light and heat, particularly for destruction of the endometrium |
US4884560A (en) | 1988-07-11 | 1989-12-05 | Kuracina Thomas C | Thermal massage device |
US4928038A (en) | 1988-09-26 | 1990-05-22 | General Electric Company | Power control circuit for discharge lamp and method of operating same |
US4945239A (en) | 1989-03-29 | 1990-07-31 | Center For Innovative Technology | Early detection of breast cancer using transillumination |
US5263951A (en) | 1989-04-21 | 1993-11-23 | Kerus Medical Systems | Correction of the optical focusing system of the eye using laser thermal keratoplasty |
US5486172A (en) | 1989-05-30 | 1996-01-23 | Chess; Cyrus | Apparatus for treating cutaneous vascular lesions |
US5057104A (en) | 1989-05-30 | 1991-10-15 | Cyrus Chess | Method and apparatus for treating cutaneous vascular lesions |
US5182557A (en) | 1989-09-20 | 1993-01-26 | Semborg Recrob, Corp. | Motorized joystick |
DE3936367A1 (en) | 1989-11-02 | 1991-05-08 | Simon Pal | SHAVER |
FR2655849B1 (en) | 1989-12-19 | 1997-10-31 | Raymond Bontemps | LOCAL CRYOGENIC DEVICE FOR MASSAGE OF THE SKIN. |
SE465953B (en) | 1990-04-09 | 1991-11-25 | Morgan Gustafsson | DEVICE FOR TREATMENT OF UNDESECTED EXTERNAL ACCOMMODATIONS |
US5059192A (en) | 1990-04-24 | 1991-10-22 | Nardo Zaias | Method of hair depilation |
US5071417A (en) | 1990-06-15 | 1991-12-10 | Rare Earth Medical Lasers, Inc. | Laser fusion of biological materials |
US5549660A (en) | 1990-11-15 | 1996-08-27 | Amron, Ltd. | Method of treating acne |
US5065515A (en) | 1991-01-24 | 1991-11-19 | Warner-Lambert Company | Thermally assisted shaving system |
US5300097A (en) | 1991-02-13 | 1994-04-05 | Lerner Ethan A | Fiber optic psoriasis treatment device |
US5207671A (en) | 1991-04-02 | 1993-05-04 | Franken Peter A | Laser debridement of wounds |
US5178617A (en) | 1991-07-09 | 1993-01-12 | Laserscope | System for controlled distribution of laser dosage |
US5474549A (en) | 1991-07-09 | 1995-12-12 | Laserscope | Method and system for scanning a laser beam for controlled distribution of laser dosage |
US5225926A (en) | 1991-09-04 | 1993-07-06 | International Business Machines Corporation | Durable optical elements fabricated from free standing polycrystalline diamond and non-hydrogenated amorphous diamond like carbon (dlc) thin films |
US5267399A (en) | 1991-09-09 | 1993-12-07 | Johnston William A | Implement for simultaneous skin chilling and chilled gel application |
US5370642A (en) | 1991-09-25 | 1994-12-06 | Keller; Gregory S. | Method of laser cosmetic surgery |
US5817089A (en) * | 1991-10-29 | 1998-10-06 | Thermolase Corporation | Skin treatment process using laser |
US5226907A (en) | 1991-10-29 | 1993-07-13 | Tankovich Nikolai I | Hair removal device and method |
US5871480A (en) * | 1991-10-29 | 1999-02-16 | Thermolase Corporation | Hair removal using photosensitizer and laser |
US5425728A (en) | 1991-10-29 | 1995-06-20 | Tankovich; Nicolai I. | Hair removal device and method |
US5344418A (en) * | 1991-12-12 | 1994-09-06 | Shahriar Ghaffari | Optical system for treatment of vascular lesions |
US5275596A (en) | 1991-12-23 | 1994-01-04 | Laser Centers Of America | Laser energy delivery tip element with throughflow of vaporized materials |
IL100545A (en) | 1991-12-29 | 1995-03-15 | Dimotech Ltd | Apparatus for photodynamic therapy treatment |
US5405368A (en) | 1992-10-20 | 1995-04-11 | Esc Inc. | Method and apparatus for therapeutic electromagnetic treatment |
US5334191A (en) | 1992-05-21 | 1994-08-02 | Dix Phillip Poppas | Laser tissue welding control system |
DE69311478T2 (en) | 1992-09-07 | 1998-01-02 | Philips Electronics Nv | Method for producing a block-shaped carrier body for a semiconductor component |
US5683380A (en) | 1995-03-29 | 1997-11-04 | Esc Medical Systems Ltd. | Method and apparatus for depilation using pulsed electromagnetic radiation |
US5626631A (en) * | 1992-10-20 | 1997-05-06 | Esc Medical Systems Ltd. | Method and apparatus for therapeutic electromagnetic treatment |
US5720772A (en) * | 1992-10-20 | 1998-02-24 | Esc Medical Systems Ltd. | Method and apparatus for therapeutic electromagnetic treatment |
US5620478A (en) | 1992-10-20 | 1997-04-15 | Esc Medical Systems Ltd. | Method and apparatus for therapeutic electromagnetic treatment |
US6280438B1 (en) * | 1992-10-20 | 2001-08-28 | Esc Medical Systems Ltd. | Method and apparatus for electromagnetic treatment of the skin, including hair depilation |
US5334193A (en) | 1992-11-13 | 1994-08-02 | American Cardiac Ablation Co., Inc. | Fluid cooled ablation catheter |
US5707403A (en) * | 1993-02-24 | 1998-01-13 | Star Medical Technologies, Inc. | Method for the laser treatment of subsurface blood vessels |
DE9303352U1 (en) * | 1993-03-08 | 1993-07-22 | Elfo Ag Sachseln, Sachseln, Ch | |
US5304170A (en) | 1993-03-12 | 1994-04-19 | Green Howard A | Method of laser-induced tissue necrosis in carotenoid-containing skin structures |
US5350376A (en) | 1993-04-16 | 1994-09-27 | Ceramoptec, Inc. | Optical controller device |
US5403306A (en) | 1993-06-22 | 1995-04-04 | Vanderbilt University | Laser surgery method |
US5860967A (en) * | 1993-07-21 | 1999-01-19 | Lucid, Inc. | Dermatological laser treatment system with electronic visualization of the area being treated |
US5415654A (en) | 1993-10-05 | 1995-05-16 | S.L.T. Japan Co., Ltd. | Laser balloon catheter apparatus |
US5885211A (en) * | 1993-11-15 | 1999-03-23 | Spectrix, Inc. | Microporation of human skin for monitoring the concentration of an analyte |
US5458140A (en) * | 1993-11-15 | 1995-10-17 | Non-Invasive Monitoring Company (Nimco) | Enhancement of transdermal monitoring applications with ultrasound and chemical enhancers |
US5413587A (en) | 1993-11-22 | 1995-05-09 | Hochstein; Peter A. | Infrared heating apparatus and methods |
US5358503A (en) | 1994-01-25 | 1994-10-25 | Bertwell Dale E | Photo-thermal therapeutic device and method |
US5505726A (en) | 1994-03-21 | 1996-04-09 | Dusa Pharmaceuticals, Inc. | Article of manufacture for the photodynamic therapy of dermal lesion |
US5616140A (en) | 1994-03-21 | 1997-04-01 | Prescott; Marvin | Method and apparatus for therapeutic laser treatment |
JP3263275B2 (en) * | 1994-04-05 | 2002-03-04 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | Apparatus for laser treatment of living tissue and laser treatment apparatus for flame-like nevus |
US5519534A (en) | 1994-05-25 | 1996-05-21 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Irradiance attachment for an optical fiber to provide a uniform level of illumination across a plane |
US5531740A (en) | 1994-09-06 | 1996-07-02 | Rapistan Demag Corporation | Automatic color-activated scanning treatment of dermatological conditions by laser |
US5522813A (en) | 1994-09-23 | 1996-06-04 | Coherent, Inc. | Method of treating veins |
US5531739A (en) | 1994-09-23 | 1996-07-02 | Coherent, Inc. | Method of treating veins |
US5662643A (en) | 1994-09-28 | 1997-09-02 | Abiomed R & D, Inc. | Laser welding system |
US5735884A (en) * | 1994-10-04 | 1998-04-07 | Medtronic, Inc. | Filtered feedthrough assembly for implantable medical device |
AT403654B (en) * | 1994-12-01 | 1998-04-27 | Binder Michael Dr | DEVICE FOR THE OPTICAL EXAMINATION OF HUMAN SKIN AND THE SAME ASSIGNMENT EVALUATION DEVICE |
US5558667A (en) | 1994-12-14 | 1996-09-24 | Coherent, Inc. | Method and apparatus for treating vascular lesions |
US5735844A (en) * | 1995-02-01 | 1998-04-07 | The General Hospital Corporation | Hair removal using optical pulses |
US5595568A (en) | 1995-02-01 | 1997-01-21 | The General Hospital Corporation | Permanent hair removal using optical pulses |
US5868731A (en) * | 1996-03-04 | 1999-02-09 | Innotech Usa, Inc. | Laser surgical device and method of its use |
US5885273A (en) * | 1995-03-29 | 1999-03-23 | Esc Medical Systems, Ltd. | Method for depilation using pulsed electromagnetic radiation |
US5660836A (en) | 1995-05-05 | 1997-08-26 | Knowlton; Edward W. | Method and apparatus for controlled contraction of collagen tissue |
DE29508077U1 (en) * | 1995-05-16 | 1995-08-10 | Wilden Lutz Dr Med | Oral care device |
US5658323A (en) | 1995-07-12 | 1997-08-19 | Miller; Iain D. | Method and apparatus for dermatology treatment |
US5879376A (en) * | 1995-07-12 | 1999-03-09 | Luxar Corporation | Method and apparatus for dermatology treatment |
US6350276B1 (en) * | 1996-01-05 | 2002-02-26 | Thermage, Inc. | Tissue remodeling apparatus containing cooling fluid |
US5630811A (en) | 1996-03-25 | 1997-05-20 | Miller; Iain D. | Method and apparatus for hair removal |
US5742392A (en) * | 1996-04-16 | 1998-04-21 | Seymour Light, Inc. | Polarized material inspection apparatus |
US5662644A (en) | 1996-05-14 | 1997-09-02 | Mdlt, Inc. | Dermatological laser apparatus and method |
US5655547A (en) | 1996-05-15 | 1997-08-12 | Esc Medical Systems Ltd. | Method for laser surgery |
US5743901A (en) * | 1996-05-15 | 1998-04-28 | Star Medical Technologies, Inc. | High fluence diode laser device and method for the fabrication and use thereof |
DE69722414T2 (en) * | 1996-07-03 | 2004-05-19 | Altea Therapeutics Corp. | MULTIPLE MECHANICAL MICROPERFORATION OF SKIN OR MUCOSA |
US6096029A (en) * | 1997-02-24 | 2000-08-01 | Laser Skin Toner, Inc. | Laser method for subsurface cutaneous treatment |
US6214034B1 (en) * | 1996-09-04 | 2001-04-10 | Radiancy, Inc. | Method of selective photothermolysis |
EP0927544B1 (en) * | 1996-09-10 | 2003-02-05 | Grigory Borisovich Altshuler | Toothbrush |
US6653618B2 (en) * | 2000-04-28 | 2003-11-25 | Palomar Medical Technologies, Inc. | Contact detecting method and apparatus for an optical radiation handpiece |
US6015404A (en) * | 1996-12-02 | 2000-01-18 | Palomar Medical Technologies, Inc. | Laser dermatology with feedback control |
US6508813B1 (en) * | 1996-12-02 | 2003-01-21 | Palomar Medical Technologies, Inc. | System for electromagnetic radiation dermatology and head for use therewith |
US7204832B2 (en) * | 1996-12-02 | 2007-04-17 | Pálomar Medical Technologies, Inc. | Cooling system for a photo cosmetic device |
US6517532B1 (en) * | 1997-05-15 | 2003-02-11 | Palomar Medical Technologies, Inc. | Light energy delivery head |
US6050990A (en) * | 1996-12-05 | 2000-04-18 | Thermolase Corporation | Methods and devices for inhibiting hair growth and related skin treatments |
US5830208A (en) * | 1997-01-31 | 1998-11-03 | Laserlite, Llc | Peltier cooled apparatus and methods for dermatological treatment |
US5891063A (en) * | 1997-04-03 | 1999-04-06 | Vigil; Arlene | Skin rejuvinating system |
DK0991372T3 (en) * | 1997-05-15 | 2004-12-06 | Palomar Medical Tech Inc | Apparatus for dermatological treatment |
US6030399A (en) * | 1997-06-04 | 2000-02-29 | Spectrx, Inc. | Fluid jet blood sampling device and methods |
US5883471A (en) * | 1997-06-20 | 1999-03-16 | Polycom, Inc. | Flashlamp pulse shaper and method |
US5885274A (en) * | 1997-06-24 | 1999-03-23 | New Star Lasers, Inc. | Filament lamp for dermatological treatment |
WO2000053261A1 (en) * | 1999-03-08 | 2000-09-14 | Asah Medico A/S | An apparatus for tissue treatment and having a monitor for display of tissue features |
US6176854B1 (en) * | 1997-10-08 | 2001-01-23 | Robert Roy Cone | Percutaneous laser treatment |
FR2772274B1 (en) * | 1997-12-16 | 2002-01-04 | Galderma Rech Dermatologique | DEVICE COMPRISING A CHROMOPHORE COMPOSITION FOR APPLICATION ON THE SKIN, METHOD FOR MANUFACTURING SUCH A DEVICE AND USES THEREOF |
IL122840A (en) * | 1997-12-31 | 2002-04-21 | Radiancy Inc | Apparatus and methods for removing hair |
AU1934699A (en) * | 1998-01-07 | 1999-07-26 | Kim Robin Segal | Diode laser irradiation and electrotherapy system for biological tissue stimulation |
US7048731B2 (en) * | 1998-01-23 | 2006-05-23 | Laser Abrasive Technologies, Llc | Methods and apparatus for light induced processing of biological tissues and of dental materials |
US6530915B1 (en) * | 1998-03-06 | 2003-03-11 | Spectrx, Inc. | Photothermal structure for biomedical applications, and method therefor |
US6173202B1 (en) * | 1998-03-06 | 2001-01-09 | Spectrx, Inc. | Method and apparatus for enhancing flux rates of a fluid in a microporated biological tissue |
US6022316A (en) * | 1998-03-06 | 2000-02-08 | Spectrx, Inc. | Apparatus and method for electroporation of microporated tissue for enhancing flux rates for monitoring and delivery applications |
WO1999049937A1 (en) * | 1998-03-27 | 1999-10-07 | The General Hospital Corporation | Method and apparatus for the selective targeting of lipid-rich tissues |
US6223071B1 (en) * | 1998-05-01 | 2001-04-24 | Dusa Pharmaceuticals Inc. | Illuminator for photodynamic therapy and diagnosis which produces substantially uniform intensity visible light |
DE19836649C2 (en) * | 1998-08-13 | 2002-12-19 | Zeiss Carl Meditec Ag | Medical handpiece |
US6663659B2 (en) * | 2000-01-13 | 2003-12-16 | Mcdaniel David H. | Method and apparatus for the photomodulation of living cells |
US6936044B2 (en) * | 1998-11-30 | 2005-08-30 | Light Bioscience, Llc | Method and apparatus for the stimulation of hair growth |
US6183500B1 (en) * | 1998-12-03 | 2001-02-06 | Sli Lichtsysteme Gmbh | Process and apparatus for the cosmetic treatment of acne vulgaris |
US6514242B1 (en) * | 1998-12-03 | 2003-02-04 | David Vasily | Method and apparatus for laser removal of hair |
US6183773B1 (en) * | 1999-01-04 | 2001-02-06 | The General Hospital Corporation | Targeting of sebaceous follicles as a treatment of sebaceous gland disorders |
SE522249C2 (en) * | 1999-01-13 | 2004-01-27 | Biolight Patent Holding Ab | Control device for controlling external processing by light |
US6709269B1 (en) * | 2000-04-14 | 2004-03-23 | Gregory B. Altshuler | Apparatus and method for the processing of solid materials, including hard tissues |
US6685699B1 (en) * | 1999-06-09 | 2004-02-03 | Spectrx, Inc. | Self-removing energy absorbing structure for thermal tissue ablation |
US6210425B1 (en) * | 1999-07-08 | 2001-04-03 | Light Sciences Corporation | Combined imaging and PDT delivery system |
US6743222B2 (en) * | 1999-12-10 | 2004-06-01 | Candela Corporation | Method of treating disorders associated with sebaceous follicles |
US6354370B1 (en) * | 1999-12-16 | 2002-03-12 | The United States Of America As Represented By The Secretary Of The Air Force | Liquid spray phase-change cooling of laser devices |
US6702808B1 (en) * | 2000-09-28 | 2004-03-09 | Syneron Medical Ltd. | Device and method for treating skin |
US20020149326A1 (en) * | 2001-03-01 | 2002-10-17 | Mikhail Inochkin | Flashlamp drive circuit |
DE10123926A1 (en) * | 2001-03-08 | 2002-09-19 | Optomed Optomedical Systems Gmbh | irradiation device |
US6679837B2 (en) * | 2001-06-01 | 2004-01-20 | Intlas Ltd. | Laser light irradiation apparatus |
US6723090B2 (en) * | 2001-07-02 | 2004-04-20 | Palomar Medical Technologies, Inc. | Fiber laser device for medical/cosmetic procedures |
US20030032900A1 (en) * | 2001-08-08 | 2003-02-13 | Engii (2001) Ltd. | System and method for facial treatment |
JP2005500108A (en) * | 2001-08-15 | 2005-01-06 | リライアント テクノロジーズ,インコーポレイティド | Apparatus and method for thermal excision of biological tissue |
US20040082940A1 (en) * | 2002-10-22 | 2004-04-29 | Michael Black | Dermatological apparatus and method |
WO2003057059A1 (en) * | 2001-12-27 | 2003-07-17 | Palomar Medical Technologies, Inc. | Method and apparatus for improved vascular related treatment |
US6863781B2 (en) * | 2002-02-26 | 2005-03-08 | Massachusetts Institute Of Technology | Process for photocatalysis and two-electron mixed-valence complexes |
CN1652729A (en) * | 2002-03-12 | 2005-08-10 | 帕洛玛医疗技术公司 | Method and apparatus for hair growth management |
ATE410965T1 (en) * | 2002-04-09 | 2008-10-15 | Altshuler Gregory | DEVICE FOR PROCESSING HARD MATERIALS |
BR0312430A (en) * | 2002-06-19 | 2005-04-26 | Palomar Medical Tech Inc | Method and apparatus for treating skin and subcutaneous conditions |
JP2007531544A (en) * | 2003-07-11 | 2007-11-08 | リライアント・テクノロジーズ・インコーポレイテッド | Method and apparatus for fractionated light treatment of skin |
US8870856B2 (en) * | 2003-08-25 | 2014-10-28 | Cutera, Inc. | Method for heating skin using light to provide tissue treatment |
-
2003
- 2003-06-19 JP JP2004516013A patent/JP2006500972A/en active Pending
- 2003-06-19 BR BR0311901-7A patent/BR0311901A/en not_active Application Discontinuation
- 2003-06-19 EP EP03737199A patent/EP1523283A1/en not_active Withdrawn
- 2003-06-19 CN CNB038140454A patent/CN100482182C/en not_active Expired - Fee Related
- 2003-06-19 AU AU2003238302A patent/AU2003238302B2/en not_active Ceased
- 2003-06-19 WO PCT/US2003/019474 patent/WO2004000150A1/en active Application Filing
- 2003-06-19 US US10/465,137 patent/US7351252B2/en active Active
- 2003-06-19 CA CA2487987A patent/CA2487987C/en not_active Expired - Fee Related
-
2004
- 2004-11-28 IL IL197542A patent/IL197542A/en active IP Right Grant
- 2004-11-28 IL IL165418A patent/IL165418A/en active IP Right Grant
-
2006
- 2006-01-09 HK HK06100339.4A patent/HK1080341A1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
HK1080341A1 (en) | 2006-04-28 |
AU2003238302A1 (en) | 2004-01-06 |
CN100482182C (en) | 2009-04-29 |
US7351252B2 (en) | 2008-04-01 |
EP1523283A1 (en) | 2005-04-20 |
IL165418A0 (en) | 2006-01-15 |
IL165418A (en) | 2009-11-18 |
CA2487987A1 (en) | 2003-12-31 |
AU2003238302B2 (en) | 2008-12-11 |
WO2004000150A1 (en) | 2003-12-31 |
JP2006500972A (en) | 2006-01-12 |
BR0311901A (en) | 2005-04-05 |
US20040093042A1 (en) | 2004-05-13 |
CN1665453A (en) | 2005-09-07 |
IL197542A (en) | 2015-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2487987C (en) | Method and apparatus for photothermal treatment of tissue at depth | |
US8915948B2 (en) | Method and apparatus for photothermal treatment of tissue at depth | |
US20230031914A1 (en) | Device including rf source of energy and vacuum system | |
US20160220834A1 (en) | Method and system for skin treatment | |
US20040162596A1 (en) | Methods and apparatus for performing photobiostimulation | |
US20100286673A1 (en) | Method and apparatus for treatment of tissue | |
Levenberg | Clinical experience with a TriPollar™ radiofrequency system for facial and body aesthetic treatments | |
JP2003521305A (en) | Method and apparatus for performing medical treatment using long-term electromagnetic radiation | |
JP2008500846A (en) | Method and product for making a grid of EMR-treated isolated points in tissue and use thereof | |
KR20210068607A (en) | Ultrasound treatment system | |
KR20120090007A (en) | Devices and methods for percutaneous energy delivery | |
KR20050024353A (en) | Method and apparatus for treatment of cutaneous and subcutaneous conditions | |
Pahlevan et al. | HIFU and RF Therapy in Facial Rejuvenation | |
Lee et al. | Non-ablative Lasers | |
CN117580612A (en) | System and method for increasing metabolic rate | |
Garibyan et al. | 12 Body contouring: Noninvasive fat reduction | |
David et al. | Non-Ablative Lasers | |
Sadick et al. | Cellulite treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |